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Abstract
Listeria monocytogenes is a bacterial pathogen that causes listeriosis, an illness that is the
third-leading cause of death related to foodborne illness. Antimicrobial compounds are currently
being investigated as a method for inactivating and/or inhibiting the growth of L. monocytogenes
in foods, with the ultimate goal of reducing recalls, illnesses, and outbreaks. Based on promising
results in other ready-to-eat foods, the efficacy of acidified calcium sulfate with lactic acid
(ACSL), beta-resorcylic acid (BR), caprylic acid (CA), -polylysine (EPL), hydrogen peroxide
(HP), lauric arginate ethyl ester (LAE), and sodium caprylate (SC) was determined in broth, milk,
and fresh cheese. Antimicrobials were tested alone and in binary combination in Brain Heart
Infusion (BHI) broth over 24 hours, in ultra-high-temperature pasteurized (UHT) milk over 21
days, and/or through application of aqueous dips to fresh cheese [Queso Fresco (QF)] that was
then stored for 35 days. Binary combinations were tested to identify antimicrobial interactions,
especially synergism, which can reduce usage rates, cost, and potential sensorial changes. Overall,
HP was the most efficacious single treatment with concentrations of 40-50 ppm inhibiting L.
monocytogenes in broth, 200 ppm resulting in undetectable pathogen counts in milk, and a 5% dip
treatment resulting in <1 log CFU/g of L. monocytogenes recovered from QF. Interactions in broth
were characterized using Fractional Inhibitory and Bactericidal Concentration indices (FIC I and
FBCI, respectively), with an index of <0.5 denoting synergy. A total of thirteen synergistic
combinations were identified in broth initially adjusted to either pH 7.4 or 5.5. Sodium caprylate
was the most common antimicrobial identified among effective combinations. The combination of
EPL + LAE was the most synergistic combination for the inactivation of L. monocytogenes in
broth at pH 7.4, with an FBCI of 0.292. Effective concentrations of EPL and LAE increased
approximately ten-fold in milk with inhibitory concentrations of 200 ppm and 800 ppm,

x

respectively, whereas CA and SC produced inhibition at similar concentrations in both media. The
most effective antimicrobial pairings for controlling L. monocytogenes in QF were ACSL+SC,
LAE+SC, and EPL+SC. These combinations resulted in significantly lower counts of L.
monocytogenes after 35 days of storage compared to the control and their respective individual
treatments. These results together identify antimicrobial treatments effective at reducing and/or
inhibiting the growth of L. monocytogenes in varying conditions and matrices and serve as a basis
for additional applications in food.

xi

Chapter I
Introduction

1

According to the Centers for Disease and Control Prevention (CDC), an estimated 47.8
million cases of foodborne illness occur each year. Among the 31 specified foodborne pathogens,
Listeria monocytogenes infections result in approximately 1600 illnesses and 260 deaths per year
(CDC, 2014). The illness caused by L. monocytogenes infection is known as listeriosis. Listeriosis
can lead to meningitis, septicemia, and pregnancy complications such as still birth and is the third
leading cause of death related to foodborne illness. Groups that are at high-risk for infection
include pregnant women, children, the elderly, and the immunocompromised (CDC, 2014).
In the past five years, there have been twelve documented outbreaks of listeriosis, most
often linked to the consumption of dairy products (cheese, ice cream, raw milk) and produce
(cantaloupes, salad, sprouts). The diversity of foods involved in outbreaks shows the ability of L.
monocytogenes to adapt to different food matrices and their storage environments. Listeria
monocytogenes is particularly robust; it can survive and grow at temperatures less than 0˚C (Vos
et al., 2011), moderately acidic pH (4-5), and high salinity environments (Schirmer et al., 2014).
Several L. monocytogenes outbreaks have been directly linked to fresh pasteurized soft cheeses.
In 2015 a multistate outbreak resulted in 30 recorded cases of listeriosis, in which the L.
monocytogenes strains isolated in cases matched strains isolated from environmental swabs taken
from the processing facility (CDC, 2015). Also, in 2014 a multistate outbreak of L. monocytogenes
linked to soft cheese resulted in eight cases of reported illness. Strains isolated from patients
matched those isolated from the processing facility (CDC, 2014). While raw milk can be
contaminated with the pathogen directly (Sanaa et al., 1993), these outbreaks were a result of postpasteurization contamination due to the presence of L. monocytogenes in the processing facility
(Almeida et al., 2013).
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Within the processing facility L. monocytogenes persists in areas such as drains, floors, and
worker footwear (D’Amico & Donnelly, 2009). Molecular typing of isolates has shown that the
same strains of L. monocytogenes can persist in food processing facilities for long periods of time,
ranging from 2 years (D’Amico & Donnelly, 2009) to as long as 12 years (Orsi et al, 2008),
displaying the resilient nature of the pathogen. Once contaminated, dairy products with certain
desirable growth characteristics allow L. monocytogenes populations to grow. Mexican-style soft
cheeses such as Queso Fresco (QF) have been implicated in several outbreaks and have been
shown to support the growth of L. monocytogenes due to their high moisture content, pH >6.0, and
low salt content (Van Hekken et al., 2012). Studies have demonstrated that L. monocytogenes can
grow to levels as high as 8 log CFU/g in as quickly as 7 days at 10˚C (Leggett et al., 2012), as well
as in QF stored at proper refrigeration temperature (4˚C). Microbial risk assessments suggest that
aside from preventing contamination, the best method for reducing illness occurrence is by limiting
L. monocytogenes growth in contaminated foods (Chen et al., 2003). Thus, there is a need to
identify treatment methods that can effectively reduce levels of L. monocytogenes and inhibit its
growth in foods.
The use of antimicrobial compounds to control the growth of L. monocytogenes has been
effective in the ready-to-eat (RTE) meat and poultry industries. The application of antimicrobial
compounds is a method that can be applied after lethality steps such as pasteurization in an effort
to control post-pasteurization contamination. Although other lethality approaches such as highpressure processing have been shown to initially reduce L. monocytogenes levels, regrowth of the
pathogen over the length of storage may occur (Koseki et al., 2007; Turgis et al., 2012) further
highlighting the need for post-lethality treatments. Several antimicrobials have demonstrated
potential for controlling L. monocytogenes either alone or in binary combinations including
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acidified calcium sulfate (Brandt et al., 2011), beta-resorcylic acid (Upadhyay et al., 2014),
caprylic acid (Gadotti et al., 2014), sodium caprylate (Almeida et al., 2013), -polylysine
(Geornaras et al., 2007), hydrogen peroxide (Upadhyay et al., 2013), and lauric arginate ethyl ester
(Soni et al., 2010).
The specific objectives of this research are as follows:
1)
a. Determine the minimum inhibitory concentration (MIC) and minimum bactericidal
concentration (MBC) of individual antimicrobials against Listeria monocytogenes in a
broth system at pH 7.4 or 5.5.
b. Determine the inhibitory and bactericidal concentrations of antimicrobials against
Listeria monocytogenes when applied in binary combinations in a broth system at pH
levels 7.4 and 5.5.
c. Characterize antimicrobial interactions as synergistic, additive, or antagonistic.
2) Determine the efficacy of antimicrobials treatments to control L. monocytogenes in whole
milk during refrigerated shelf life.
3) Determine the efficacy of antimicrobial dip treatments to control L. monocytogenes as
surface contaminants on fresh cheese.
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1. Listeria monocytogenes
1.1. Microbiology/Detection
The taxonomy of Listeria monocytogenes is as follows: Kingdom Bacteria, Division
Firmicutes, Class Bacilli, Order Bacillales, Family Listeriaceae, Genus Listeria (Vos et al., 2011).
Within the genus of Listeria, only two species are known to be pathogenic to animals. Listeria.
ivanovii is pathogenic to a wide variety of animal species whereas L. monocytogenes is the only
Listeria spp. that is pathogenic to humans and is therefore the microorganism of concern in terms
of human food safety. Listeria monocytogenes was first classified by E.D.G Murray under the
name Bacterium monocytogenes (Murray et al., 1926), and was later changed to the name
“Listeria” by J.H. Pirie (Pirie, 1940). Listeria monocytogenes strains are further classified into
serotypes based on somatic (O) and flagellar (H) antigens (Weis & Seeliger, 1975). Currently there
are two major phylogenetic divisions of serotypes, with a third consisting of less common
serotypes (Borucki & Call, 2003). Of the identified serotypes, studies have found that >90% of
clinical cases of listeriosis involve serotypes 1/2a, 1/2b, and 4b (Tappero et al., 1995), with the
majority of genetic differences being attributed to phage insertions, transposable elements, and
single nucleotide polymorphisms (Nelson et al., 2004). The genus exists as short rods, usually 0.40.5µm x 1-2 µm. When stained, L. monocytogenes is Gram-positive and not acid fast. Filaments
may be formed, but only in cultures that are grown at temperatures <30˚C (Vos et al., 2011).
Listeria monocytogenes is a facultative anaerobe with an optimal growth temperature of 30-37˚C.
However, it is capable of growing from the range of <0 to 45˚C (Vos et al., 2011). This is
particularly important in regards to foodborne illness because it facilitates the growth and survival
of L. monocytogenes in foods at refrigeration temperatures (4-7˚C), which is a common method of
food preservation. The optimal pH level for growth is between 6 and 9, although survival has been
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demonstrated at pH levels of 4.5-5.0 (Schirmer et al., 2014). Listeria monocytogenes also has the
ability to grow in environments with salt concentrations as high as 10% (Vos et al., 2011) and
survive at 20% and higher (Schirmer et al., 2014).
1.2. Pathogenicity
The virulence factors that result in pathogenesis are controlled by the transcriptional
regulator PrfA, (Mandin et al., 2005). When L. monocytogenes colonizes the gut through cell
adhesion involving the Ami protein (Milohanic et al., 2004), it is able to enter cells using two
internalization proteins known as internalin A (InlA) and B (InlB). While both are involved in
entry into epithelial cells, InlA in its non-truncated form has been found in approximately 96% of
L. monocytogenes strains isolated from foodborne outbreaks (Jacquet et al., 2004), suggesting its
importance in virulence and human listeriosis. Once inside the cell, Listeria are able to grow
intracellularly using hemolysin (Portnoy, 1988) and evade vacuoles through the secretion of
listeriolysin O (LLO) (Cossart et al., 1989) and PlcA (Camilli et al., 1993). Once it has escaped,
L. monocytogenes uses actin protein to move from cell to cell, triggering an immune response that
is the basis for many of the initial symptoms of illness.
Listeriosis is the illness that occurs when L. monocytogenes infects both humans and
animals. As soon as hours after consumption, flu-like symptoms are the first indication of
listeriosis. Without proper treatment listeriosis may manifest itself in a number of ways, including
but not limited to meningitis, encephalitis, septicemia, intrauterine infection, and death (Batt,
2014). Approximately 1600 cases are recorded in the United States each year, with approximately
260 of those cases resulting in mortality (CDC, 2014). The most commonly affected groups
include children, the elderly, the immunocompromised, and pregnant women and their fetuses.
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Listeria monocytogenes is notable amongst foodborne pathogens in that it has one of the
highest mortality rates, third only to Salmonella and Toxoplasma gondii (FDA, 2014). While the
infectious dose of L. monocytogenes is not completely known, it is believed to vary based on strain
type and susceptibility of the host. However, for severely immunocompromised individuals, less
than 1000 cells are needed to cause an infection (FDA, 2016). Infectious dose has also been
speculated to be dependent upon the food matrix upon which it grows. For example, L.
monocytogenes grown in foods with high salt concentrations at ambient temperatures results in a
high rate of intracellular invasion by the pathogen (Garner et al., 2006). Environmental stressors
such as salt and pH can influence how virulent the specific bacteria become. For example,
adaptation to a low pH before ingestion increases the ability of L. monocytogenes to survive the
stomach acid (Conte et al., 2002).
1.3. Listeria in the Environment
There are several ways that L. monocytogenes enters the food system, starting in the natural
environment and continuing into the processing facility itself. Within the food industry, so-called
“critical control points” (CCP) are designated to identify points within the processing protocol
where foods are at high-risk for contamination by biological, physical, and/or chemical agents. At
these CCPs, action is taken to prevent or eliminate contamination. In raw milk, pasteurization is
not performed and as a result any existing L. monocytogenes are not destroyed. Even though
pasteurization eliminates pre-existing L. monocytogenes in pasteurized products, post-processing
contamination is not uncommon due to the presence of L. monocytogenes in processing facilities.
In nature, L. monocytogenes is ubiquitous, present in soil, water, feeding grounds, and feces
(Weis & Seeliger, 1975). The presence of L. monocytogenes in a food processing environment
begins with transmission of the pathogen from an outside source, such as from a farm environment.
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When a food-processing facility is directly adjacent to a farm (such as with production of farmstead
cheeses), L. monocytogenes that is present on the farm can easily be transmitted to the production
facility. If the facility is not near a farm, the pathogen can be brought into the facility via fomites
such as worker boots. Researchers studying the presence of L. monocytogenes in dairy facilities
have shown that the pathogen may be harbored in drains, doorways, and footwear (D’Amico &
Donnelly, 2009). Through the use of molecular typing, strains of Listeria have been found to
persist in dairy processing facilities for as long as 12 years (Orsi et al., 2008). Without proper good
manufacturing practices (GMPs) in place, the pathogen can subsequently contaminate food
products. One way in which Listeria can persist in food processing facilities is through biofilms.
A biofilm is a community of bacteria that has attached itself to a surface (O’Toole et al., 2000). In
a food processing facility, biofilms can form on a number of different surfaces including polyester
floor sealant, nylon, and stainless steel (Alessandria et al., 2010; Blackman & Frank, 1996). With
inadequate sanitation practices, biofilms pose a substantial risk for post-processing contamination.
1.4. Listeria in Dairy Foods
According to the Centers for Disease Control and Prevention (CDC), there have been seven
recorded listeriosis outbreaks in dairy foods since 2011 (CDC, 2016). In addition, there have been
at least 10 recalls associated with L. monocytogenes contamination in dairy foods in 2016 alone
(FDA, 2016). Soft cheese including the Mexican-style varieties such as Queso Fresco are
disproportionately implicated. “Queso Fresco” translates to “fresh cheese”, and is considered a
high-risk food for L. monocytogenes contamination and outbreaks. Studies have shown that L.
monocytogenes can grow to levels of 8-9 log CFU/ml in milk (Ma et al., 2013) and Queso Fresco
(QF) (Gadotti et al., 2014), even when stored at refrigeration temperature. As described by Van
Hekken et al. (2012), QF is one of the most popular fresh cheeses in the United States. It is bright
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white, crumbles easily, has a mild “fresh-milk” flavor, and does not melt well. The composition
of this cheese varies, but ranges from 46-57% moisture, 18-29% fat, 1-3% salt, and has a pH >6.1
(Van Hekken & Farkye, 2003). In the US, Queso Fresco must be made with pasteurized milk in
order to be sold across state lines. However, raw milk regulations vary by state, so although the
use of pasteurized milk reduces risk of pathogenic outbreaks, it is not necessarily required (Gould
et al., 2014). One of the first and most notable outbreaks linked to QF was in 1985 in Los Angeles
County, California. In total, 142 cases of listeriosis were reported, 93 of which were pregnant
women or their fetuses. Forty-eight resulted in death (Linley et al., 2012). The company
responsible for this outbreak had been using non-pasteurized milk in addition to their pasteurized
milk. Upon investigation of the dairy plant, it was uncovered that unlicensed employees had been
pasteurizing the milk. This investigation also confirmed presence of Listeria in the processing
environment. This historical case brought attention to L. monocytogenes in dairy products and
began a national effort to prevent future outbreaks. In 1990, a study was conducted in California
to look at Mexican-style soft cheeses across the state, tracking the presence of pathogens and the
characteristics of the cheeses in which these pathogens were detected (Genigeorgis et al., 1991).
Across 100 cheeses sampled, 31 were determined to have been made from improperly pasteurized
milk, which is known to harbor Listeria (Lovett et al., 1987). The average salt concentration of
these samples was 1.87% and the average moisture content was 50.09%. A total of four samples
were positive for Listeria, and the cheese samples positive for Listeria ranged in pH from 6.1-6.5.
This study elucidates the risk factors associated with the survival and growth of L. monocytogenes
in Mexican-style soft cheeses: high-moisture, low salt content, and near-neutral pH.
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1.5. Methods for detection in foods
The standard method for the detection of L. monocytogenes in foods in the US is described
in the FDA’s Bacteriological Analytical Manual (BAM) (FDA, 2016). For a given sample, 25g is
mixed with 225ml of Buffered Listeria Enrichment Broth (BLEB) with pyruvate. After
homogenization by stomaching, the sample is incubated at 30˚C for 4 hours; after 4 hours three
selective supplements are added (cycloheximide, acriflavin, and nalidixic acid). The sample is
mixed and incubated at 30˚C for the remaining part of 24 to 48 hours. At 24 and 48 hours, samples
are streaked onto two media, one esculin-based and one chromogenic. Esculin-based agars allow
for the selection of all Listeria species. Examples of esculin-based agars are Oxford, PALCAM,
and Modified Oxford (MOX), upon which Listeria colonies appear black with a back halo and
after 48 hours of incubation, a sunken center. To further classify Listeria by species, Chromogenic
agars (i.e. CHROMagar Listeria ID) further identify the species based on colony color (caused by
enzymatic activity, which releases a chromophore) and presence of a halo due to phospholipase
activity. Listeria monocytogenes is also able to be differentiated based on a number of defining
characteristics such as the inability to use mannitol and xylose and the ability to use rhamnose.
2. Antimicrobials
An antimicrobial is any compound that inhibits the growth of or kills microorganisms
including bacteria, viruses, parasites, and fungi (FDA, 2016). The use of antimicrobial compounds
in food is regulated by the FDA under the Food Drug & Cosmetic Act, with respect to both raw
agricultural commodities and processed foods. The status of each compound in regard to its usage
in foods is outlined in the Code of Federal Regulations (CFR) Title 21, which is reserved for rules
mandated by the FDA. Food additives are classified as either direct or indirect. A direct food
additive is added for a specific purpose, whereas an indirect additive makes its way into a food
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product indirectly in trace amounts (i.e. through packaging). Before an additive can be used, it
must be preapproved by the FDA, which in short occurs when the FDA has received enough
scientific evidence that the additive is safe for human consumption. Direct additives may either be
approved as prior-sanctioned ingredients (classified as safe before 1958), or Generally Recognized
as Safe (GRAS) based on scientific consensus either prior to 1958 or through research (FDA,
2016). Antimicrobials directly added to food with the purpose of inhibiting microorganisms are
classified as food additives. Even if approved for usage in foods, an antimicrobial compound may
have limitations concerning the levels that may be used and in which foods. For additives that have
been reportedly used but full toxicology reports are not yet in place, the additive falls under the
category of “Everything Added to Food in the United States” (EAFUS) (FDA, 2014).
2.1. Antimicrobial Susceptibility Testing
There are a number of methods employed in the research community to determine the
susceptibility of a microorganism to a specific antimicrobial (Jorgensen & Ferraro, 2009). One
common approach is the broth dilution method. Broth dilution assays use serial dilutions
(commonly two-fold) of antimicrobials in broth, to which a microorganism is added. Turbidity of
the broth after incubation indicates whether or not the antimicrobial at a given concentration
inhibits growth. Two important terms that are used to describe antimicrobial susceptibility are the
minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC). These
terms refer to the lowest concentration of a compound at which growth inhibition and cell death
occur, respectively. Although many definitions exist, for this thesis the MIC is defined as the
concentration of a given compound whereby bacterial counts change ≤ 0.5 log CFU/ml or gram
compared to initial inoculation. Furthermore, MBC is defined as the concentration of a given
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compound that reduces bacterial counts by >3 log CFU/ml or gram compared to initial inoculation
(Brandt et al, 2010).
Concentration of an antimicrobial compound that do not produce growth inhibition are
known as sub-inhibitory or sub-lethal. Sub-lethal concentrations can pose a concern due to the
development of antimicrobial resistance. Research indicates that exposure to sub-lethal
concentrations of antimicrobials can lead to mutagenesis, whereby pathogens are not
destroyed/inhibited and multidrug antimicrobial resistance occurs (Kohanski et al., 2010). On the
other hand, studies have shown that sub-inhibitory concentrations of antimicrobials can downregulate the expression of virulence genes and ultimately reduce infection (Upadhyay et al., 2012).
Therefore, when considering antimicrobial treatments, sub-inhibitory concentrations need to be
further examined for potential effects.
Antimicrobial combinations are often tested to identify whether their interactions are
synergistic, additive, or antagonistic. These terms describe the effect of a combination of
compounds in comparison to the sum of their separate effects. Synergy indicates a greater
combined effect, whereas antagonism indicates a lesser effect and additive is indifferent (Brandt
et al., 2011). Compound interactions are often classified through the determination of Fractional
Inhibitory and Bactericidal Concentrations indices (FICI and FBCI) (Hall et al., 1982) as follows:

FIC = (Concentration of Compound 1 in interaction with Compound 2)
(MIC of Compound 1 alone)
FICI = FIC Compound 1 + FIC Compound 2

FBC = (Concentration of Compound 1 in interaction with Compound 2)
(MBC of Compound 1 alone)

FBCI = FBC Compound 1 + FBC Compound 2
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Although the classifications of interactions based on FICI and FBCI are disputed and vary
across research fields and between researchers, an index of >4 is commonly considered
antagonistic, and <0.5 as synergistic. The FICI and FBCI take into account the MIC or MBC of an
individual compound and its MIC or MBC when used in combination with one or more additional
compounds. Combinations of antimicrobials are commonly tested using a checkerboard assay,
which tests antimicrobials by diluting each in an opposite direction on a microplate (Hsieh et al.,
1993). For example, in a 96-well microplate, the highest concentration of compound 1 would be
in the column on the far left, and the antimicrobial is diluted in a horizontal direction to the right.
Next, the highest concentration of compound 2 is added to the top row and diluted vertically to the
bottom of the plate. In this manner, the interactions of several different combinations of a given
antimicrobial pair can be tested.
2.2. - Polylysine (EPL)
-polylysine (EPL) is a homo-poly-amino acid characterized by a peptide bond connecting
the carboxyl and amino groups of L-lysine. It is comprised of approximately 25-35 L-lysine
residues, with peptide bond linkages between the carboxyl group and the epsilon amino groups of
the residues (Yoshida & Nagasawa, 2003):

The number of L-lysine residues is important, as it has been demonstrated that polymers with
fewer than 10 residues result in a much lower antimicrobial effect (Shima et al., 1984). -polylysine
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was originally discovered to be produced by the soil-borne bacteria Streptomyces albulus through
batch fermentation (Shima & Sakai, 1977), and is currently produced commercially on an
industrial scale. -polylysine first achieved GRAS status in 2004, but was only initially approved
for use in sushi rice/cooked rice at a maximum concentration of 50 ppm (FDA, 2004). In 2011,
EPL was then approved for usage up to 250 ppm in a variety of foods, including feta, mozzarella,
cream, and Mexican-style cheese (FDA, 2011).
-polylysine demonstrates an extensive range of antimicrobial activity across fungi, as well
as both Gram-positive and Gram-negative bacteria (Yoshida & Nagasawa, 2003). The
antimicrobial activity of EPL has been shown to rely extensively on charge, as EPL is cationic and
interacts with negative charges. The negative charges of phospholipid head groups allow EPL to
interact with bacterial cell membranes and have an effect of destabilization (Hyldgaard et al.,
2014). Antimicrobial resistance to EPL is attributed to a two-component system related to the ViRregulated operon, which was demonstrated when the inactivation of this operon increased bacterial
sensitivity to EPL (Kang et al., 2015). Differences in efficacy between Gram-negative and Grampositive bacteria occur due to the differences in cell membrane. For example, L. innocua (Grampositive) has a cell membrane that has no net-negative charge, resulting in a decreased interaction
of EPL with the cell membrane (Hyldgaard et al., 2014).
The characteristics of EPL as an antimicrobial and the optimal environment in which it
may be used has been documented. First, it has been observed that EPL is more effective when
used at physiological pH than acidic pH due to reduction of positive charges in a less acidic
environment (Najjar et al., 2007). It also has a high resistance to heat, showing no degradation
when autoclaved or boiled, implicating that it may be a good candidate for use in foods which are
subject to a heat treatment (Yoshida & Nagasawa, 2003). Antimicrobial efficacy against yeasts
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was found to decrease in the presence of pectin due to the association of EPL with anionic
substances (Chang et al., 2012), which reflects how efficacy may change depending on food
components. Similarly, EPL was found to be unstable to aggregation and precipitation in the
presence of carrageenan, a common stabilizer used in dairy foods (Lopez-Pena & McClements,
2014). This is important because it reveals how the efficacy of EPL can change based on the
presence of other components of a food system, and further highlights the important impact of the
food matrix when considering antimicrobial treatments.
The efficacy of EPL against L. monocytogenes has been demonstrated extensively, both in
broth and food matrices. In a broth system, MIC and MBC levels ranging from 10 to 100 ppm
have been reported (Amrouche et al., 2010; Geornaras et al., 2005; Kang et al., 2015; Brandt et
al., 2010). The differences in these reported concentrations reflect the effects of different growth
media, strain type, and growth conditions on the antimicrobial efficacy of EPL. Geornaras et al.
(2007) studied the effect of EPL against L. monocytogenes in various food extracts, including fatfree and whole milk, beef, bologna, rice, and vegetables. When EPL was applied at 50 and 200
ppm, there was a significant decrease in pathogen counts compared to the control on the final day
of storage for all extracts (Geornaras et al., 2007). Notable in this experiment was that there was a
more potent antimicrobial effect in foods that had a lower protein content (rice and vegetables)
compared to animal-based foods such as meats, which are high in protein from muscle tissue. This
effect is further supported in other studies. For example, the efficacy of EPL to control pathogen
growth was diminished in smoked salmon, which was attributed to high levels of protein (Kang et
al., 2014; Takahashi et al., 2011). Although EPL has demonstrated a decreased efficacy in foods
with higher protein content, it has still been shown to have a significant antimicrobial effect when
applied to some meat products. For example, EPL applied at a level of 2% reduced counts of L.
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monocytogenes by ~6 log CFU/gram on roast beef compared to the control after eight days of
refrigerated storage (Chang et al., 2010). In seafood, EPL at 10% was successfully delivered
through the use of polymer films on surimi (Muriel-Galet et al., 2014), and in tuna and salmon roe
at 0.2% (Takahashi et al., 2011).
When used in combination with other antimicrobial compounds, EPL has been shown to
produce a synergistic effect. -polylysine has been shown to work synergistically in combination
with nisin (Najjar et al., 2007), an antimicrobial derived from Lactococcus lactis, and additively
with subtilosin (Amrouche et al., 2010), an antimicrobial derived from Bacillus subtilis. Also,
when combined with either lauric arginate ethyl ester or acidified calcium sulfate with lactic acid,
a significant reduction in Salmonella on chicken carcasses was observed (Benli et al., 2011).
However, at this time data on the use of EPL in combination with other antimicrobials to control
pathogens in dairy foods are scant.
2.3. Lauric Arginate Ethyl Ester (LAE; lauric arginate; ethyl-Nα-lauroyl-L-arginine ethyl ester
monohydrochloride)
Lauric arginate (LAE) is a cationic surfactant that is derived from lauric acid, arginine,
and ethanol (Rodríguez et al., 2004). To date, LAE has GRAS approval for use in a variety of meat
and poultry products. These include comminuted and non-comminuted RTE meat products, fresh
cuts of meat and poultry, and sausages with a maximum level of 200 ppm of LAE in the finished
food product in most cases (FDA 2006). In a study by Romanova et al. (2002), it was observed
that alterations occur in the cytoplasmic membrane and in the external membrane in Gramnegative cells in the presence of LAE. However, alterations occur in the cell membrane and
cytoplasm in Gram-positive cells, with no cell lysis observed in exposed bacterial cells (Rodríguez
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et al., 2004). Cell potential is disrupted due to ion leakage as a result of these structural changes
caused by LAE.
The antimicrobial efficacy of LAE has been demonstrated heavily in both broth systems
and a variety of food matrices. Although reports of MIC and MBC are variable, studies consistently
show that LAE is effective at low concentration in broth systems, with reports of levels as low as
~12 ppm (Ma et al., 2013; Brandt et al., 2010) and 20 ppm (Techathuvanan et al., 2014) producing
inhibition. Complete inhibition in broth has also been seen at higher levels of 200 ppm (Soni et al.,
2010). The MIC and MBC were found to increase more than ten-fold when soluble starch was
added to the broth media, suggesting that the presence of starch or other carbohydrates reduces the
antimicrobial efficacy of LAE against L. monocytogenes (Ma et al., 2013). Furthermore, effective
levels of LAE against L. monocytogenes are found to be higher in 2% reduced-fat milk than in
broth, with concentrations of 375 and 750 ppm being reported as the MIC and MBC, respectively
(Ma et al., 2013). A similar study using skim and whole milk found that 200 ppm of LAE was
inhibitory to L. monocytogenes, whereas 800 ppm reduced bacteria to undetectable levels with a
greater antimicrobial effect in skim milk versus whole milk (Soni et al., 2010). These results show
that the efficacy of LAE decreases with the addition of various food components.
The antimicrobial efficacy of LAE can also be affected by components that include a
negative charge. Since LAE is cationic, it can form complexes with anionic biopolymers, leading
to aggregates. This in turn can decrease its antimicrobial activity as more of the agent becomes
bound/unavailable (Bonnaud et al., 2010). When grown on nonfat milk agar, levels of LAE at 0.1
and 0.2% resulted in no visible growth of L. monocytogenes over 24 hours of incubation (Taylor
& Lathrop, 2015). The same researchers also demonstrated that Listeria growth was inhibited by
0.2% LAE only when inoculum level was less than 4 log CFU/ml when grown on cheese agar that
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contains fat (Taylor & Lathrop, 2015), further contributing to the body of evidence that fat inhibits
the antimicrobial efficacy of LAE.
Multiple studies by Soni et al. (2010) have shown that LAE is inhibitory against L.
monocytogenes inoculated onto QF. Levels of 200 and 800 ppm reduced L. monocytogenes levels
significantly after 24 hours, but only 800 ppm inhibited growth over 28 days of storage (Soni et
al., 2010). A second study showed similar results, with 200 ppm causing significant decreases in
the pathogen load over 24 hours, with regrowth leading to levels similar to the control over the
course of 28 days of storage. These results indicate that at lower levels, LAE may not be sufficient
for inhibiting the growth of L monocytogenes in the long-term storage of QF.
Lauric arginate is also effective for an initial decrease in L. monocytogenes counts in RTE
meat products. In two separate studies, LAE was added to frankfurters and L. monocytogenes was
enumerated throughout refrigerated storage. The addition of LAE at 43 ppm (Lavieri et al., 2014)
and 44 ppm (Porto-fett et al., 2010) caused an initial reduction in L. monocytogenes, but counts
were >6 log CFU/g at 98 and 120 days of storage, respectively. A five-minute submersion of
frankfurters contaminated with L. monocytogenes in an antimicrobial dip solution containing 5000
ppm LAE reduced pathogen levels to below detection limit after 48 hours; whether or not growth
was inhibited over long-term storage was not investigated (Taormina & Dorsa, 2009). Lastly, LAE
applied by adding the aqueous antimicrobial to the food in a bag which was then vacuum-packaged
was shown to decrease levels of L. monocytogenes in commercially-prepared hams (Luchansky et
al., 2005). This method allows for the antimicrobial to be distributed over the entire surface of the
food, and will therefore be more likely to make contact with any cells that are present. A similar
method was used to apply 200 ppm of LAE to cold-smoked salmon (Soni et al., 2014), which
resulted in undetectable levels of L. monocytogenes after 24 hours.

21

When applied in combination with other antimicrobial compounds, the antibacterial effects
of LAE can be enhanced by combining mechanisms of action. For example, LAE paired with nisin
produces membrane-channel formation, which leads to cell lysis and ion leakage (Pattanayaiying
et al., 2014). Lauric arginate has also been found to work additively with the plant-derived
antimicrobials cinnamaldehyde, eugenol, and thymol (Ma et al., 2013), as well as white mustard
essential oil and flavonoid blends (Techathuvanan et al., 2014). Lauric arginate has also been
shown to reduce L. monocytogenes counts when applied through the use of polylactic acid and
pullulan coatings applied to the surface of ham (Theinsathid et al., 2012; Pattanayaiying et al.,
2015), and with alternative treatments such as ultraviolet light (Sommers et al., 2010). Negative
organoleptic (sensorial) changes have been documented with the application of this antimicrobial
to foods. Although consumers could not detect any sensorial differences in QF that had 200 ppm
of LAE applied (Soni et al., 2010), lower levels of LAE applied to frankfurters produced noticeable
changes after prolonged storage (Martin et al., 2009).
2.4. Caprylic Acid and Sodium Caprylate (CA; octanoic acid / SC; sodium octanoate)
Caprylic acid (CA) (C8H16O2) is a medium chain saturated fatty acid, consisting of 8
carbons (Marten et al., 2006). It has the chemical structure (Pubchem, 2004):

It is present naturally in a variety of foods including milk and coconut oil, from which it is often
commercially produced through fermentation and distillation of volatile fatty acids
(21CFR172.860). However, it can also be produced by oxidation of n-octanol (21CFR172.860).
Sodium caprylate (SC) is the sodium salt derivative of CA, and is completely soluble in water
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whereas CA is less soluble in water and solubilizes completely in alcohol and ether. It has the
chemical formula C8H15NaO2, and structure (Pubchem, 2016):

Caprylic acid is approved for usage in cheese at levels up 400 ppm (21CFR184.1025).
Sodium caprylate is a useful alternative to CA because it solubilizes completely in water, making
it easier to incorporate into a variety of applications. At the time of writing, there has been no
reported limits on the usage of SC and no available toxicology reports. The antimicrobial
properties of fatty acids and their derivatives has been tested against a wide variety of
microorganisms, including Salmonella Enteriditis (Vasudevan et al., 2005), bacterial mastitis
pathogens (Nair et al., 2005), bacterial fish pathogens (Kollanoor et al., 2007), Dermatophilus
congolensi (a pathogen that causes rain rot in animals) (Valipe et al., 2011), and Listeria (Wang &
Johnson, 1992). Its antimicrobial properties are largely attributed to the free carboxyl group, which
aids in the breakage of cellular membranes (Kabara et al., 1972). It has also been shown that fatty
acids including CA significantly reduce the ability of L. monocytogenes to invade mammalian cells
(Wang & Johnson, 1992). Therefore, even if antimicrobial activity does not result in complete
inactivation, CA may reduce the ability of surviving cells to infect a host. Also, the efficacy of
anionic surface agents (fatty acids) is reduced at physiological pH level (Kabara et al., 1972),
suggesting that CA may be a more effective antimicrobial in foods of an acidic nature.
The antimicrobial properties of CA against L. monocytogenes have been demonstrated in
broth systems, giving indication for its ability to inhibit the pathogen in the absence of confounding

23

factors. Even at sub-inhibitory levels (<5 mM), CA reduces the lag time and maximum specific
growth of L. monocytogenes (Nobmann et al., 2009). In tryptose phosphate broth (TPB) adjusted
to pH 5.0, the MIC of a commercial mixture of CA and SC (Octa-Gone, Ecolab, St. Paul, MN) has
been reported as 25 ppm (Brandt et al., 2011). Petrone et al. (1998) reported growth inhibition at
20 ppm and bactericidal activity at 200 ppm when grown at pH 5.0. In contrast, growth was
unaffected at the same antimicrobial concentrations when tested at pH 7.0, suggesting that CA has
increased antimicrobial efficacy at more acidic pH levels, which has also been reported by
Kinderlerer et al. (1992). However, the reported MIC data vary, with other research groups
reporting an MIC as 2360 ppm in unadjusted tryptic soy broth (TSB, pH 7.0) and 2830 ppm in
TSB adjusted to pH 5.5 (Nakai & Siebert, 2004), which may be attributed to slightly different pH
levels and differences in pathogen strains.
The ability of CA to reduce levels of L. monocytogenes in both produce and animal-based
products has also been tested. A 2% wash solution of CA reduced levels of L. monocytogenes on
cantaloupes to undetectable levels after 5 minutes at high temperature (Upadhyay et al., 2014). In
milk stored at 8˚C, 50mM of CA reduced L. monocytogenes levels approximately 2.5 log CFU/ml
after 48 hours (Nair et al., 2004). Despite initial pathogen reductions, studies using CA as an antilisterial agent in RTE meats have shown that inhibitory properties are limited, with initial
reductions followed by outgrowth. When applied to frankfurters, 376.11 ppm of CA resulted in an
initial decrease in L. monocytogenes counts to undetectable levels over 14 days of refrigerated
storage, at which point outgrowth occurred throughout the remaining storage period (Lavieri et al.,
2014). A similar effect was seen when CA was applied to RTE hams, with initial inhibition
followed by outgrowth by 70 days of storage (Lavieri et al., 2014).
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Other antimicrobial compounds have been tested in combination with CA to identify
additive, synergistic, and antagonistic effects. When applied to QF, CA at levels 360-720 ppm in
combination with nisin were effective at inhibiting the growth of L. monocytogenes (Gadotti et al.,
2014). When 2% CA was paired with hydrogen peroxide at 2%, no significant difference was seen
in levels of L. monocytogenes compared to CA 2% alone (Upadhyay et al., 2014), showing that
CA works well on its own. However, CA has been shown to exhibit a moderately synergistic effect
in combination with oregano essential oil in minced beef (Hulankova et al. 2011, 2013), and with
acidified calcium sulfate with lactic acid in broth (Brandt et al., 2011).
To date, data demonstrating the efficacy of SC against L. monocytogenes are scant.
However, its antimicrobial properties have been demonstrated against a number of other
organisms. For example, 120mM of SC completely eliminated Escherichia coli in drinking water
throughout 20 days (Amalaradjou et al., 2006). The effective anti-listerial concentrations for SC
were higher than for CA against four bacterial fish pathogens, with effective concentrations of SC
ranging from 25-100mM (Kollanoor et al., 2007). Similarly, when tested against Dermatophilus
congolensis, a bacterial pathogen causing illness in both animals and humans, the MIC and MBC
of SC were higher than CA, with concentrations of SC ranging from 15-75 mM (Valipe et al.,
2011). These data suggest that SC has a reduced antimicrobial efficacy compared to CA. However,
SC is water soluble and its ability to work in synergy with other antimicrobials has not been
investigated.
2.5. Hydrogen Peroxide (HP)
Hydrogen peroxide (HP) (H2O2) is a strong oxidizing agent that dissociates into hydrogen
and water in an exothermic reaction (Pubchem, 2016). The chemical structure of HP is relatively
simple:
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Hydrogen peroxide is used in many industries including the food industry as a disinfectant and
sanitizer or as an antimicrobial agent added directly to foods. For example, HP has been proposed
for use as a post-harvest wash to disinfect apples that may be contaminated with E. coli (Sapers &
Sites 2003). As of April 2016, HP has GRAS status for use in 13 food categories. It is allowable
for use in milk intended to make cheese (up to 500 ppm) and in whey (up to 400 ppm)
(21CFR184.1366). Although the antimicrobial mechanism of HP is not completely understood,
there is strong evidence of the Fenton reaction, in which HP reacts with metal ions such as iron
and produces hydroxyl radicals (Juven & Pierson, 1996). These radicals result in the oxidation of
important bacterial biomolecules such as proteins, lipids, and DNA (Linley et al., 2012).
When comparing the antimicrobial susceptibility of L. monocytogenes in the form of
planktonic cells versus biofilms, biofilms exhibit a stronger resistance to HP (Zameer & Gopal,
2010; Yun et al., 2012). Furthermore, in a study exploring the sensitivity of 19 strains of L.
monocytogenes to common sanitizers, it was found that the MIC varies depending on strain, but is
within the range of 9.4-75 ppm (Romanova et al., 2002). Higher concentrations of HP are needed
for bactericidal activity. For example, a 1% solution of HP in Miller’s Lysogeny broth produced a
4-log reduction in stationary phase L. monocytogenes cells after 15 minutes (Le et al., 2015). Chill
brines are used to quickly bring foods to low temperatures, but are a potential source of L.
monocytogenes contamination (Parikh et al., 2011). When applied at a level of 0.4%, HP reduced
pathogen counts to undetectable levels after two hours (Parikh et al., 2011).
The use of HP as a direct food additive to control L. monocytogenes has been explored in
various food matrices. Hydrogen peroxide has also been shown to have antimicrobial efficacy

26

when applied as a wash solution. For example, a 2% wash solution of HP reduced L.
monocytogenes levels on contaminated cantaloupes by at least 5 CFU/cm2 in 3 minutes and to
undetectable levels depending on the temperature of storage (Upadhyay et al., 2014). Hydrogen
peroxide can also be applied as a vapor. Application of a 10% concentration of HP in the form of
vapor resulted in a 3-log reduction of L. monocytogenes when applied to lettuce (Back et al., 2014).
Several groups have demonstrated that HP works in combination with other antimicrobials
to produce a synergistic effect. Hydrogen peroxide in combination with plant-derived
antimicrobials reduced levels of L. monocytogenes on frankfurters (65˚C) to undetectable levels
over 70 days of storage (Upadhyay et al., 2013), and on cantaloupes within minutes at temperatures
55˚C and higher (Upadhyay et al., 2014). An increased antimicrobial effect of HP has also been
shown when used in combination with alternative treatments such as UV radiation (Parikh et al.,
2011). Potential organoleptic changes (smell, taste, odor, etc.) in foods treated with HP present
one limitation to broad adoption. Oxidants such as HP can lead to negative organoleptic changes
such as rancidity in foods high in fat (Smith et al., 2015; Wambura & Yang, 2011) and thereby
reduce shelf-life. Another aspect of using HP as an antimicrobial is that it can inhibit beneficial
bacteria. Hydrogen peroxide can inhibit the growth and acid production of lactic starter cultures
even at very low levels (Subramanian & Olson, 1968). Residual HP in a product can be neutralized
with the addition of the enzyme catalase, which causes HP to dissociate into oxygen and water. In
the case of use of HP in cultured products, this can prevent HP from negatively influencing
beneficial bacteria. Residual HP can be tested using strips which produce a color reaction,
depending on the amount of HP detected.
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2.6. Acidified Calcium Sulfate
Acidified calcium sulfate (ACS) products are available commercially from the Mionix
company. These include Safe2O RTE01 (ACS and lactic acid (ACSL)), and RTE03 (ACS and
propionic acid (ACSP)). Both products are a unique mixture of sulfuric acid, calcium sulfate,
calcium hydroxide, and their respective organic acids. Both are highly acidic with a pH of <2.0.
Since L. monocytogenes ideally grows in the pH range 6-9, addition of a highly acidic product is
thought to disrupt pH homeostasis. Currently, ACSL is approved (GRAS) for use on several
animal food products including raw and cooked chicken, beef jerky, comminuted beef, and RTE
meats (USDA-FSIS, 2009). Acidified calcium sulfate with propionic acid is approved for use in
RTE meat products (i.e. hot dogs) where it may be applied using a spray technique.
Research using the ACS products listed above show that these compounds are effective in
reducing pathogenic foodborne bacteria in both broth and food systems. Brandt et al. (2010)
reported that ACSL is inhibitory against L. monocytogenes at 1,560 ppm and bactericidal at 6,250
ppm in TPB adjusted to pH 5.0 (Brandt et al., 2011). This same group found in a separate study
that inhibition and bactericidal activity both occur at higher levels (12,500 ppm) in unadjusted
TPB (pH ~7.0), showing that the antimicrobial efficacy of ACSL is affected by pH. When applied
to contaminated ham, a 1:2 solution of ACSL significantly reduced Listeria counts. This study did
not sample further than 24 hours, so it is not known if bacterial levels remained low or if outgrowth
subsequently occurred. When applied to chicken, ACS has been shown to reduce levels of
Salmonella (Benli et al., 2011) as well as maintain quality by reducing levels of spoilage bacteria
(Mehyar et al., 2005).
Acidifed calcium sulfate with lactic acid has been shown to work synergistically in
combination with LAE and nisin in broth pH 7.0 (Brandt et al., 2010), and with OctaGone in broth
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acidified to pH 5.0 (Brandt et al., 2011). In a study investigating the efficacy of antimicrobials to
reduce common foodborne pathogens on pre-rigor beef rounds, ACSL in combination with EPL
produced greater bacterial reductions than when used alone (Njongmeta et al., 2011). The ability
of ACS to work synergistically with other antimicrobials is important because these combinations
allow for a lower usage rate, which could prevent organoleptic changes attributed to the application
of ACS, such as changes in aftertaste, texture, and aromatics (Nuñez de Gonzalez et al., 2006). It
is currently approved for usage in the meat and poultry industry, and may be used in amounts
“sufficient for purpose” (USDA/FSIS 2004).
2.7. Beta-Resorcylic Acid (BR, 2,4-dihydroxybenzoic acid)
Plant-derived antimicrobials have been demonstrated to exert inhibitory effects against
pathogenic bacteria, both Gram-positive and Gram-negative (Burt et al., 2004). Beta-resorcylic
acid (BR) (C7H6o4) is a phytophenolic compound that is commonly found among the angiosperms
of plants (Julkunen-Tiitto, 1985), with the given structure (Pubchem, 2016):

Beta-resorcylic acid is listed under EAFUS meaning it has reportedly been used as an additive but
toxicology research has not yet been completed. Therefore, direct addition of BR is not yet
approved for usage without toxicology studies to determine toxicity and rule out long-term effects.
The mechanism of action for BR is not well documented at this time. Beta-resorcylic acid has
shown to be effective at inhibiting the growth of both Gram-positive and Gram-negative bacteria,

29

including Staphylococcus aureus and Escherichia coli (Alves et al., 2013). The antimicrobial
efficacy of BR against L. monocytogenes has been tested several times. However, the highest
concentration of BR tested in these studies (1000 ppm) was not effective at inhibiting growth on
its own (Friedman et al., 2003; Alves et al., 2013). Beta-resorcylic acid applied through a chitosan
coating at 2% on cantaloupes reduced L. monocytogenes to undetectable levels over the course of
7 days, compared to the control which reached >7 log CFU/cm2 (Upadhyay et al., 2014). In this
same study, L. monocytogenes was not detectable when contaminated cantaloupes were washed
with a 2% solution of BR, but only at high temperature (65˚C). A study by this same group of
researchers looked at BR to inactivate L. monocytogenes on frankfurters. A 1.5% solution of BR
was used as a dip treatment, and after 50 days of refrigerated storage Listeria was still present at
levels >3 log CFU/cm2 (Upadhyay et al., 2013), whereas in the control levels stayed consistently
between 4 and 5 log CFU/cm2 . One potential hindrance to broad application is that BR does not
dissolve in water alone. In most studies a 4% dimethyl sulfoxide (DMSO) solution has been
reportedly used as a solvent (Capriotti & Capriotti, 2012). DMSO is not currently recognized as
GRAS, but falls under EAFUS as well.
3. Hypothesis and Objectives
Based on published research regarding antimicrobials and their ability to inhibit the growth
of L. monocytogenes, it was hypothesized that the antimicrobials ACSL, BR, CA, EPL, HP, LAE,
and SC would exhibit inhibitory and bactericidal activity against L. monocytogenes both alone and
in binary combinations. It was further hypothesized that the use of antimicrobials combinations
would exert synergistic effects, thereby minimizing antimicrobial application while maintaining
equivalent inhibition and inactivation levels.
The specific objectives of this research are as follows:
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1)
a. Determine the minimum inhibitory concentration (MIC) and minimum bactericidal
concentration (MBC) of individual antimicrobials against Listeria monocytogenes
in a broth system at pH 7.4 or 5.5.
b. Determine the inhibitory and bactericidal concentrations of antimicrobials against
Listeria monocytogenes when applied in binary combinations in a broth system at
pH levels 7.4 and 5.5.
c. Characterize antimicrobial interactions as synergistic, additive, or antagonistic.
2) Determine the efficacy of antimicrobials treatments to control L. monocytogenes in whole
milk during refrigerated shelf life.
3) Determine the efficacy of antimicrobial dip treatments to control L. monocytogenes as
surface contaminants on fresh cheese.

4. References
Alessandria, V., K. Rantsiou, P. Dolci, and L. Cocolin. 2010. Molecular methods to assess
Listeria monocytogenes route of contamination in a dairy processing plant. Int. J. Food
Microbiol. 141:S156–S162.
Alves, M. J., I. C. F. R. Ferreira, H. J. C. Froufe, R. M. V. Abreu, A. Martins, and M.
Pintado. 2013. Antimicrobial activity of phenolic compounds identified in wild mushrooms,
SAR analysis and docking studies. J. Appl. Microbiol. 115:346–357.
Amalaradjou, M. A. R., T. Annamalai, P. Marek, P. Rezamand, D. Schreiber, T. Hoagland,
and K. Venkitanarayanan. 2006. Inactivation of Escherichia coli O157:H7 in cattle drinking
water by sodium caprylate. J. Food Prot. 69: 2248-2252.
Amrouche, T., K. S. Noll, Y. Wang, Q. Huang, and M. L. Chikindas. 2010. Antibacterial
activity of subtilosin alone and combined with curcumin, poly-lysine and zinc lactate against
Listeria monocytogenes strains. Probiotics Antimicrob. Proteins 2:250–257.

31

Back, K.-H., J.-W. Ha, and D.-H. Kang. 2014. Effect of hydrogen peroxide vapor treatment
for inactivating Salmonella Typhimurium, Escherichia coli O157:H7 and Listeria
monocytogenes on organic fresh lettuce. Food Control 44:78–85.
Benli, H., M. X. Sanchez-Plata, and J. T. Keeton. 2011. Efficacy of -polylysine, lauric
arginate, or acidic calcium sulfate applied sequentially for Salmonella reduction on
membrane filters and chicken carcasses. J. Food Prot. 74:743–50.
Blackman, I. C., and J. F. Frank. 1996. Growth of Listeria monocytogenes as a biofilm on
various food-processing surfaces. J. Food Prot. 59:827-831
Bonnaud, M., J. Weiss, and D. J. McClements. 2010. Interaction of a food-grade cationic
surfactant (lauric arginate) with food-grade biopolymers (pectin, carrageenan, xanthan,
alginate, dextran, and chitosan). J. Agric. Food Chem. 58:9770–9777.
Borucki, M. K., and D. R. Call. 2003. Listeria monocytogenes serotype identification by
PCR. J. Clin. Microbiol. 41:5537–5540.
Brandt, A. L., A. Castillo, K. B. Harris, J. T. Keeton, M. D. Hardin, and T. M. Taylor. 2011.
Synergistic inhibition of Listeria monocytogenes in vitro through the combination of octanoic
acid and acidic calcium sulfate. J. Food Prot. 74:122–125.
Brandt, A. L., A. Castillo, K. B. Harris, J. T. Keeton, M. D. Hardin, and T. M. Taylor. 2010.
Inhibition of Listeria monocytogenes by food antimicrobials applied singly and in
combination. J. Food Sci. 75:M557–M563.
Burt, S. 2004. Essential oils: their antibacterial properties and potential applications in
foods—a review. Int. J. Food Microbiol. 94:223–253.
Camilli, A., L. G. Tilney, and D. A. Portnoy. 1993. Dual roles of plcA in Listeria
monocytogenes pathogenesis. Mol. Microbiol. 8:143–157.
Capriotti, K., and J. A. Capriotti. 2012. Dimethyl sulfoxide. J. Clin. Aesthetic Dermatol.
5:24–26.
Chang, S.S., W.Y.W. Lu, S.H. Park, and D.H. Kang. 2010. Control of foodborne pathogens
on ready-to-eat roast beef slurry by ε-polylysine. Int. J. Food Microbiol. 141:236–241.
Chang, Y., L. McLandsborough, and D. J. McClements. 2012. Cationic antimicrobial (εpolylysine)–anionic polysaccharide (pectin) interactions: influence of polymer charge on
physical stability and antimicrobial efficacy. J. Agric. Food Chem. 60:1837–1844.
Conte, M. P., G. Petrone, A. M. Di Biase, C. Longhi, M. Penta, A. Tinari, F. Superti, G.
Fabozzi, P. Visca, and L. Seganti. 2002. Effect of acid adaptation on the fate of Listeria
monocytogenes in THP-1 human macrophages activated by gamma interferon. Infect. Immun.
70:4369–4378.

32

Cossart, P., M. F. Vicente, J. Mengaud, F. Baquero, J. C. Perez-Diaz, and P. Berche. 1989.
Listeriolysin O is essential for virulence of Listeria monocytogenes: direct evidence obtained
by gene complementation. Infect. Immun. 57:3629.
D’Amico, D. J., and C. W. Donnelly. 2009. Detection, isolation, and incidence of Listeria
spp. in small-scale artisan cheese processing facilities: a methods comparison. J. Food Prot.
72:2499–507.
Food and Drug Administration (FDA). 2004. Agency response letter GRAS notice no. GRN
000135. Available from:
http://www.fda.gov/Food/FoodIngredientsPackaging/GenerallyRecognizedasSafeGRAS/GR
ASListings/ucm153957.htm. Accessed November 14th, 2016.
Food and Drug Administration (FDA). 2006. Agency response letter GRAS notice no. GRN
000164. Available from:
http://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm154124
.htm. Accessed November 14th, 2016.
Food and Drug Administration (FDA). 2011. Agency response letter GRAS notice no. GRN
000336. Available from:
http://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm271325
.htm. Accessed November 14th, 2016.
Food and Drug Administration (FDA). 2014. Bad bug book (Second Edition). Available at:
http://www.fda.gov/Food/FoodborneIllnessContaminants/CausesOfIllnessBadBugBook/defa
ult.htm Accessed: November 14, 2016.
Food and Drug Administration (FDA). 2014. Everything added to food in the United States
(EAFUS). Available at:
http://www.fda.gov/Food/IngredientsPackagingLabeling/ucm115326.htm. Accessed
November 16, 2016
Food and Drug Administration (FDA). 2016.Archive for recalls, market withdrawals &
safety alerts. Available at: http://www.fda.gov/Safety/Recalls/ArchiveRecalls/default.htm.
Accessed: November 14, 2016.
Food and Drug Administration (FDA). 2016. Bacteriological analytical manual (BAM).
Available at:
http://www.fda.gov/Food/FoodScienceResearch/LaboratoryMethods/ucm2006949.htm.
Accessed: November 14, 2016.
Food and Drug Administration (FDA). 2016. Code of Federal Regulations (CFR) Title 21.
Available at: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm.
Accessed: November, 14th, 2016.

33

Food and Drug Administration (FDA). 2016. Generally Recognized as Safe (GRAS).
Available at: http://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/default.htm.
Accessed: November 14, 2016.
Friedman, M., P. R. Henika, and R. E. Mandrell. 2003. Antibacterial activities of phenolic
benzaldehydes and benzoic acids against Campylobacter jejuni, Escherichia coli, Listeria
monocytogenes, and Salmonella enterica. J. Food Prot. 66:1811–1821.
Gadotti, C., L. Nelson, and F. Diez - Gonzalez. 2014. Inhibitory effect of combinations of
caprylic acid and nisin on Listeria monocytogenes in queso fresco. Food Microbiol. 39:1-6.
Garner, M. R., K. E. James, M. C. Callahan, M. Wiedmann, and K. J. Boor. 2006. Exposure
to salt and organic acids increases the ability of Listeria monocytogenes to invade Caco-2
cells but decreases its ability to survive gastric stress. Appl. Environ. Microbiol. 72:5384–
5395.
Genigeorgis, C., J. H. Toledo, and F. J. Garayzabal. 1991. Selected microbiological and
chemical characteristics of illegally produced and marketed soft Hispanic-style cheeses in
California. J. Food Prot. 54:598–601.
Geornaras, I., Y. Yoon, K. e. Belk, G. c. Smith, and J. n. Sofos. 2007. Antimicrobial activity
of ɛ-polylysine against Escherichia coli O157:H7, Salmonella Typhimurium, and Listeria
monocytogenes in various food extracts. J. Food Sci. 72:M330–M334.
Geornaras, I., and J. N. Sofos. 2005. Activity of ε–polylysine against Escherichia coli
O157:H7, Salmonella Typhimurium, and Listeria monocytogenes. J. Food Sci. 70:M404–
M408.
Hall, M.J., R.F. Middleton, D. Westmacott. 1982. The fractional inhibitory concentration
(FIC) index as a measure of synergy. J.Antimicrob. Ther. 11 (5): 427-433.
Hsieh, M.H., C.M. Yu, V.L. Yu, J.W., Chow. 1993. Synergy assessed by checkerboard a
critical analysis. Diagn. Microbiol. and Infect. Dis.16(4): 343-349.
Hulánková, R., and G. Bořilová. 2011. In vitro combined effect of oregano essential oil and
caprylic acid against Salmonella serovars, Escherichia coli O157:H7, Staphylococcus aureus
and Listeria monocytogenes. Acta Vet. Brno 80:343–348.
Hulankova, R., G. Borilova, and I. Steinhauserova. 2013. Combined antimicrobial effect of
oregano essential oil and caprylic acid in minced beef. Meat Sci. 95:190–194.
Hyldgaard, M., T. Mygind, B. S. Vad, M. Stenvang, D. E. Otzen, and R. L. Meyer. 2014. The
antimicrobial mechanism of action of epsilon-poly-l-lysine. Appl. Environ. Microbiol.
80:7758–7770.

34

Jacquet, C., M. Doumith, J. I. Gordon, P. M. V. Martin, P. Cossart, and M. Lecuit. 2004. A
molecular marker for evaluating the pathogenic potential of foodborne Listeria
monocytogenes. J. Infect. Dis. 189:2094–2100.
Jorgensen, J. H., and M. J. Ferraro. 2009. Antimicrobial susceptibility testing: a review of
general principles and contemporary practices. Clin. Infect. Dis. 49:1749–1755.
Julkunen-Tiitto, R. 1985. Phenolic constituents in the leaves of northern willows: methods
for the analysis of certain phenolics. J. Agric. Food Chem. 33:213–217.
Juven, B. J., and M. D. Pierson. 1996. Antibacterial effects of hydrogen peroxide and
methods for its detection and quantitation. J. Food Prot. 59: 1233-1241.
Kabara, J. J., D. M. Swieczkowski, A. J. Conley, and J. P. Truant. 1972. Fatty acids and
derivatives as antimicrobial agents. Antimicrob. Agents Chemother. 2:23–28.
Kang, J., M. J. Stasiewicz, D. Murray, K. J. Boor, M. Wiedmann, and T. M. Bergholz. 2014.
Optimization of combinations of bactericidal and bacteriostatic treatments to control Listeria
monocytogenes on cold-smoked salmon. Int. J. Food Microbiol. 179:1–9.
Kang, J., M. Wiedmann, K. J. Boor, and T. M. Bergholz. 2015. VirR-mediated resistance of
Listeria monocytogenes against food antimicrobials and cross-protection induced by
exposure to organic acid salts. Appl. Environ. Microbiol. 81:4553–4562.
Kinderlerer, J. L., and B. M. Lund. 1992. Inhibition of Listeria monocytogenes and Listeria
innocua by hexanoic and octanoic acids. Lett. Appl. Microbiol. 14:271–274.
Kohnaski, M.A., M.A. DePristo, J.J. Collins. 2010. Sublethal antibiotic treatment leads to
multidrug resistance via radical-induced mutagenesis. Molecular Cell. 37(3): 311-320.
Kollanoor, A., P. Vasudevan, M. K. M. Nair, T. Hoagland, and K. Venkitanarayanan. 2007.
Inactivation of bacterial fish pathogens by medium-chain lipid molecules (caprylic acid,
monocaprylin and sodium caprylate). Aquac. Res. 38:1293–1300.
Lavieri, N. A., J. G. Sebranek, B. F. Brehm-Stecher, J. C. Cordray, J. S. Dickson, A. M.
Horsch, S. Jung, E. M. Larson, D. K. Manu, and A. F. Mendonça. 2014. Investigating the
control of Listeria monocytogenes on a ready-to-eat ham product using natural antimicrobial
ingredients and postlethality interventions. Foodborne Pathog. Dis. 11:462–467.
Lavieri, N. A., J. G. Sebranek, B. F. Brehm-Stecher, J. C. Cordray, J. S. Dickson, A. M.
Horsch, S. Jung, E. M. Larson, D. K. Manu, and A. F. Mendonca. 2014. Investigating the
control of Listeria monocytogenes on alternatively-cured frankfurters using natural
antimicrobial ingredients or post-lethality interventions. Meat Sci. 97:568–574.

35

Le, P., L. Zhang, V. Lim, M. J. McCarthy, and N. Nitin. 2015. A novel approach for
measuring resistance of Escherichia coli and Listeria monocytogenes to hydrogen peroxide
using label-free magnetic resonance imaging and relaxometry. Food Control 50:560–567.
Linley, E., S. P. Denyer, G. McDonnell, C. Simons, and J.-Y. Maillard. 2012. Use of
hydrogen peroxide as a biocide: new consideration of its mechanisms of biocidal action. J.
Antimicrob. Chemother. 67:1589–1596.
Lopez-Pena, C. L., and D. J. McClements. 2014. Optimizing delivery systems for cationic
biopolymers: competitive interactions of cationic polylysine with anionic κ-carrageenan and
pectin. Food Chem. 153:9–14.
Lovett, J., D. W. Francis, and J. M. Hunt. 1987. Listeria monocytogenes in raw milk:
detection, incidence, and pathogenicity. J. Food Prot. 50: 188-192.
Luchansky, J. B., J. E. Call, B. Hristova, L. Rumery, L. Yoder, and A. Oser. 2005. Viability
of Listeria monocytogenes on commercially-prepared hams surface treated with acidic
calcium sulfate and lauric arginate and stored at 4 °C. Meat Sci. 71:92–99.
Ma, Q., P. M. Davidson, and Q. Zhong. 2013. Antimicrobial properties of lauric arginate
alone or in combination with essential oils in tryptic soy broth and 2% reduced fat milk. Int.
J. Food Microbiol. 166:77–84.
Mandin, P., H. Fsihi, O. Dussurget, M. Vergassola, E. Milohanic, A. Toledo-Arana, I. Lasa,
J. Johansson, and P. Cossart. 2005. VirR, a response regulator critical for Listeria
monocytogenes virulence: novel Listeria virulence regulon. Mol. Microbiol. 57:1367–1380.
Marten, B., M. Pfeuffer, and J. Schrezenmeir. 2006. Medium-chain triglycerides. Int. Dairy
J. 16:1374–1382.
Martin, E. M., C. L. Griffis, K. L. S. Vaughn, C. A. O’Bryan, E. C. Friedly, J. A. Marcy, S.
C. Ricke, P. G. Crandall, and J. R. Y. Lary. 2009. Control of Listeria Monocytogenes by
lauric arginate on frankfurters formulated with or without lactate/diacetate. J. Food Sci.
74:M237–M241.
Mehyar, G., G. Blank, J. H. Han, A. Hydamaka, and R. A. Holley. 2005. Effectiveness of
trisodium phosphate, lactic acid and commercial anti-microbials against pathogenic bacteria
on chicken skin. Food Prot. Trends 25:351–362.
Milohanic, E., R. Jonquières, P. Cossart, P. Berche, and J.-L. Gaillard. 2004. The autolysin
Ami contributes to the adhesion of Listeria monocytogenes to eukaryotic cells via its cell
wall anchor: Ami-mediated adhesion. Mol. Microbiol. 39:1212–1224.
Muriel-Galet, V., G. López-Carballo, R. Gavara, and P. Hernández-Muñoz. 2014.
antimicrobial properties of ethylene vinyl alcohol/epsilon-polylysine films and their
application in surimi preservation. Food Bioprocess Technol. 7:3548–3559.

36

Murray, E. G. D., R. A. Webb, and M. B. R. Swann. 1926. A disease of rabbits characterised
by a large mononuclear leucocytosis, caused by a hitherto undescribed bacillus Bacterium
monocytogenes (n.sp. J. Pathol. Bacteriol. 29:407–439.
Nair, M. K. M., P. Vasudevan, T. Hoagland, and K. Venkitanarayanan. 2004. Inactivation of
Escherichia coli O157:H7 and Listeria monocytogenes in milk by caprylic acid and
monocaprylin. Food Microbiol. 21:611–616.
Nair, M. K. M., J. Joy, P. Vasudevan, L. Hinckley, T. A. Hoagland, and K. S.
Venkitanarayanan. 2005. Antibacterial effect of caprylic acid and monocaprylin on major
bacterial mastitis pathogens. J. Dairy Sci. 88:3488–3495.
Najjar, M. B., D. Kashtanov, and M. l. Chikindas. 2007. ε-Poly-l-lysine and nisin A act
synergistically against Gram-positive food-borne pathogens Bacillus cereus and Listeria
monocytogenes. Lett. Appl. Microbiol. 45:13–18.
Nakai, S. A., and K. J. Siebert. 2004. Organic acid inhibition models for Listeria innocua,
Listeria ivanovii, Pseudomonas aeruginosa and Oenococcus oeni. Food Microbiol. 21:67–
72.
Nelson, K. E. 2004. Whole genome comparisons of serotype 4b and 1/2a strains of the foodborne pathogen Listeria monocytogenes reveal new insights into the core genome
components of this species. Nucleic Acids Res. 32:2386–2395.
Njongmeta, N. L. A., H. Benli, K. D. Dunkley, C. S. Dunkley, D. R. Miller, R. C. Anderson,
C. A. O’Bryan, J. T. Keeton, D. J. Nisbet, P. G. Crandall, and S. C. Ricke. 2011. Application
of acidic calcium sulfate and ε-polylysine to pre-rigor beef rounds for reduction of
pathogens: ACS/EPL sprays reduce pathogens on beef. J. Food Saf. 31:395–400.
Nobmann, P., A. Smith, J. Dunne, G. Henehan, and P. Bourke. 2009. The antimicrobial
efficacy and structure activity relationship of novel carbohydrate fatty acid derivatives
against Listeria spp. and food spoilage microorganisms. Int. J. Food Microbiol. 128:440–
445.
Nuñez de Gonzalez, M. T., J. T. Keeton, and L. J. Ringer. 2006. Sensory and
physicochemical characteristics of frankfurters containing lactate with antimicrobial surface
treatments. J. Food Sci. 69:S221–S228.
Orsi, O.H., M.L. Borowsky, P. Lauer, S.K. Young, Q. Sun, L.M. Graves, B. Swaminathan,
M. Wiedmann. 2008. Short-term genome evolution of Listeria monocytogenes in a noncontrolled environment. BMC Genomics. 9:539.
O’Toole, G., H. B. Kaplan, and R. Kolter. 2000. Biofilm formation as microbial
development. Annu. Rev. Microbiol. 54:49–79.

37

Parikh, P. P., R. C. Williams, P. Mallikarjunan, J. D. Eifert, and J. E. Marcy. 2011.
Concurrent use of ultraviolet light and citric acid, dimethyl dicarbonate or hydrogen peroxide
to inactivate Listeria monocytogenes in chill brine: ultraviolet light and antimicrobials for
Listeria. J. Food Saf. 31:530–537.
Pattanayaiying, R., A. H-Kittikun, and C. N. Cutter. 2014. Effect of lauric arginate, nisin Z,
and a combination against several food-related bacteria. Int. J. Food Microbiol. 188:135–
146.
Pattanayaiying, R., A. H-Kittikun, and C. N. Cutter. 2015. Incorporation of nisin Z and lauric
arginate into pullulan films to inhibit foodborne pathogens associated with fresh and readyto-eat muscle foods. Int. J. Food Microbiol. 207:77–82.
Pirie, J. H. 1940. Listeria: change of name for a genus bacteria. Nature 145:264.
Portnoy, D. A. 1988. Role of hemolysin for the intracellular growth of Listeria
monocytogenes. J. Exp. Med. 167:1459–1471.
Porto-Fett, A.C.S., S.G. Campano, J.L. Smith, A. Oser, B.Shoyer, J.E.Call, J.B. Luchansky.
2010. Control of Listeria monocytogenes on commercially-produced frankfurters prepared
with and without potassium lactate and sodium diacetate and surface treated with lauric
arginate using the Sprayed Lethality in Container (SLIC®) delivery method. Meat Sci. 85(2):
312-318
Pubchem. 2016. 2,4-dihydroxybenzoic acid. Available at:
https://pubchem.ncbi.nlm.nih.gov/compound/2_4-dihydroxybenzoic_acid. Accessed:
November 14th, 2016.
Pubchem. 2016. Hydrogen Peroxide. Available at:
https://pubchem.ncbi.nlm.nih.gov/compound/hydrogen_peroxide. Accessed: November 14,
2016.
Pubchem. 2004. Octanoic Acid. Available at:
https://pubchem.ncbi.nlm.nih.gov/compound/octanoic_acid#section=Top. Accessed:
November 14th, 2016.
Pubchem. 2016. Sodium Octanoate. Available at:
https://pubchem.ncbi.nlm.nih.gov/compound/sodium_octanoate#section=Top. Accessed:
November 14, 2016.
Rodríguez, E., J. Seguer, X. Rocabayera, and A. Manresa. 2004. Cellular effects of
monohydrochloride of l-arginine, Nα-lauroyl ethylester (LAE) on exposure to Salmonella
Typhimurium and Staphylococcus aureus. J. Appl. Microbiol. 96:903–912.
Romanova, N., S. Favrin, and M. W. Griffiths. 2002. Sensitivity of Listeria monocytogenes
to sanitizers used in the meat processing industry. Appl. Environ. Microbiol. 68:6405–6409.

38

Sapers, G.M., and J.E. Sites. 2003. Efficacy of 1% hydrogen peroxide wash in
decontaminating apples and cantaloupe melons. J. Food Sci.; 68: 1793 – 1797.
Schirmer, B. C. T., E. Heir, B.-A. Lindstedt, T. Møretrø, and S. Langsrud. 2014. Use of used
vs. fresh cheese brines and the effect of pH and salt concentration on the survival of Listeria
monocytogenes. J. Dairy Res. 81:113–119.
Shima, S., H. Matsuoka, T. Iwamoto, and H. Sakai. 1984. Antimicrobial action of - poly-Llysine. J. Antibiot. (Tokyo) 37:1449–1455.
Shima, S., and H. Sakai. 1977. Polylysine produced by Streptomyces. Agric. Biol. Chem.
41:1807–1809.
Smith, T. J., E. A. Foegeding, and M. Drake. 2015. Sensory and functionality differences of
whey protein isolate bleached by hydrogen or benzoyl peroxide J. Food Sci. 80:C2153–
C2160.
Sommers, C. H., O. J. Scullen, and J. E. Sites. 2010. Inactivation of foodborne pathogens on
frankfurters of foodborne pathogens on frankfurters using ultraviolet light and GRAS
antimicrobials. J. Food Saf. 30: 666-678.
Soni, K. A., R. Nannapaneni, M. W. Schilling, and V. Jackson. 2010. Bactericidal activity of
lauric arginate in milk and Queso Fresco cheese against Listeria monocytogenes cold growth.
J. Dairy Sci. 93:4518–4525.
Soni, K. A., Q. Shen, and R. Nannapaneni. 2014. Reduction of Listeria monocytogenes in
cold-smoked salmon by bacteriophage P100, nisin and lauric arginate, singly or in
combinations. Int. J. Food Sci. Technol. 49:1918–1924.
Subramanian, C. S., and N. F. Olson. 1968. Effect of hydrogen peroxide on activity of lactic
cultures in milk. J. Dairy Sci. 51:517–519.
Takahashi, H., S. Kuramoto, S. Miya, H. Koiso, T. Kuda, and B. Kimura. 2011. Use of
commercially available antimicrobial compounds for prevention of Listeria monocytogenes
growth in ready-to-eat minced tuna and salmon roe during shelf life. J. Food Prot. 74:994–
998.
Taormina, P. J., and W. J. Dorsa. 2009. Short-term bactericidal efficacy of lauric arginate
against Listeria monocytogenes present on the surface of frankfurters. J. Food Prot.
72:1216–24.
Tappero, J. W. 1995. Reduction in the incidence of human listeriosis in the United States:
effectiveness of prevention efforts? JAMA 273:1118.

39

Taylor, T. M., and A. A. Lathrop. 2015. Evaluation of antimicrobials and salt replacers for
use in low-sodium dairy products: antimicrobials for dairy applications. J. Food Saf. 35:32–
40.
Techathuvanan, C., F. Reyes, J. R. D. David, and P. M. Davidson. 2014. Efficacy of
commercial natural antimicrobials alone and in combinations against pathogenic and spoilage
microorganisms. J. Food Prot. 77:269–75.
Theinsathid, P., W. Visessanguan, J. Kruenate, Y. Kingcha, and S. Keeratipibul. 2012.
Antimicrobial activity of lauric arginate-coated polylactic acid films against Listeria
monocytogenes and Salmonella Typhimurium on cooked sliced ham. J. Food Sci. 77:M142–
M149.
United States Department of Agriculture, Food Safety and Inspection Service (USDA-FSIS).
2009. Safe and suitable ingredients used in the production of meat, poultry, and egg products
(Directive 7120.1, Rev. 2). Available from:
http://www.fsis.usda.gov/OPPDE/rdad/FSISDirectives/7120.1Rev2.pdf. Accessed November
14th, 2016.
Upadhyay, A., I. Upadhyaya, A. Kollanoor-Johny, S. Ananda Baskaran, S. Mooyottu, D.
Karumathil, and K. Venkitanarayanan. 2013. Inactivation of Listeria monocytogenes on
frankfurters by plant-derived antimicrobials alone or in combination with hydrogen peroxide.
Int. J. Food Microbiol. 163:114–118.
Upadhyay, A., A. Kollanoor-Johny, M. A. R. Amalaradjou, S. A. Baskaran, K. S. Kim, K.
Venkitanarayanan 2012. Plant-derived antimicrobials reduce Listeria monocytogenes
virulence factors in vitro, and down-regulate expression of virulence genes. International
Journal of Food Microbiology. 157(1): 88-94.
Upadhyay, A., I. Upadhyaya, S. Mooyottu, A. Kollanoor-Johny, and K. Venkitanarayanan.
2014. Efficacy of plant-derived compounds combined with hydrogen peroxide as
antimicrobial wash and coating treatment for reducing Listeria monocytogenes on
cantaloupes. Food Microbiol. 44:47–53.
USDA/FSIS (2009). Safe and suitable ingredients used in the production of meat and poultry
products. FSIS Directive 7120.1 Amendment 6, USDAFSIS. Available at:
https://www.fsis.usda.gov/wps/wcm/connect/bab10e09-aefa-483b-8be8809a1f051d4c/7120.1.pdf?MOD=AJPERES. Accessed December 5, 2016.
Valipe, S. R., J. A. Nadeau, T. Annamali, K. Venkitanarayanan, and T. Hoagland. 2011. In
vitro antimicrobial properties of caprylic acid, monocaprylin, and sodium caprylate against
Dermatophilus congolensis. Am. J. Vet. Res. 72:331–335.
Van Hekken, D. L., and N. Y. Farkye. 2003. Hispanic cheeses: The quest for queso. Food
Technol. 57:32–38.

40

Vasudevan, P., P. Marek, M. K. M. Nair, T. Annamalai, M. Darre, M. Khan, and K.
Venkitanarayanan. 2005. In vitro inactivation of Salmonella Enteritidis in autoclaved chicken
cecal contents by caprylic acid. J. Appl. Poult. Res. 14:122–125.
Vos, P., G. Garrity, D. Jones, N. R. Krieg, W. Ludwig, F. A. Rainey, K.-H. Schleifer, and W.
Whitman. 2011. Bergey’s manual of systematic bacteriology: Volume 3: The Firmicutes.
Springer Science & Business Media.
Wambura, P., and W. Yang. 2011. Influence of power ultrasound on oxidative rancidity of
potato chips. J. Food Process Eng. 34:1046–1052.
Wang, L. L., and E. A. Johnson. 1992. Inhibition of Listeria monocytogenes by fatty acids
and monoglycerides. Appl. Environ. Microbiol. 58:624–629.
Weis, J., and H. P. R. Seeliger. 1975. Incidence of Listeria monocytogenes in nature. Appl.
Microbiol. 30:29–32.
Yoshida, T., and T. Nagasawa. 2003. ε-Poly-l-lysine: microbial production, biodegradation
and application potential. Appl. Microbiol. Biotechnol. 62:21–26.
Yun, H. S., Y. Kim, S. Oh, W. M. Jeon, J. F. Frank, and S. H. Kim. 2012. Susceptibility of
Listeria monocytogenes biofilms and planktonic cultures to hydrogen peroxide in food
processing environments. Biosci. Biotechnol. Biochem. 76:2008–2013.
Zameer, F., and S. Gopal. 2010. Impact of hydrogen peroxide on growth and survival of
Listeria Monocytogenes biofilms. E-J. Chem. 7:1008–1012.

41

Chapter III:
Synergistic antimicrobial combinations inhibit and inactivate Listeria monocytogenes
in neutral and acidic broth systems
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1. Abstract
The use of effective antimicrobials to reduce Listeria monocytogenes levels in ready-to-eat
(RTE) foods and prevent pathogen growth can be limited by regulation of usage levels, cost, and
organoleptic changes. The identification of combinatorial approaches to produce additive,
synergistic, and antagonistic effects is desirable to limit usage levels without diminishing
inhibitory or bactericidal effects. The present study identified minimum inhibitory (MIC) and
minimum bactericidal concentrations (MBC) of antimicrobials when used alone or in binary
combinations against L. monocytogenes in growth media adjusted to pH 7.4 and 5.5. Resulting
interactions were characterized as synergistic, additive, or antagonistic. When applied alone at pH
7.4, lauric arginate (LAE) and ε-polylysine (EPL) were effective at the lowest concentrations with
MICs of 6.25 and 20 ppm, respectively. Lauric arginate was also the most effective antimicrobial
at pH 5.5 with an MIC of 10 ppm. Efficacy of caprylic acid (CA) and sodium caprylate (SC) was
enhanced in broth at the lower pH with MICs of 50 ppm. With reference to bactericidal
concentrations, EPL, HP, and LAE had the lowest MBCs in broth adjusted to both pH 7.4 (60, 50,
and 25 ppm, respectively) and pH 5.5 (300, 100, and 20 ppm, respectively). Two inhibitory
combinations at pH 7.4 and three at pH 5.5 were classified as synergistic. Five synergistic
bactericidal combinations were identified in broth pH 7.4, with three identified at pH 5.5. The most
synergistic bactericidal pairing was EPL + LAE. Of all synergistic combinations identified, SC
was involved in approximately half. No combinations were characterized as antagonistic. These
data serve as a basis for identifying effective antimicrobial approaches at varying pH levels for
more effective application for the control of L. monocytogenes in foods.

43

2. Introduction
An estimated 1600 illness and 260 deaths occur annually in the U.S. due to foodborne
listeriosis, an illness caused by the bacterial pathogen Listeria monocytogenes (Scallan et al.,
2011). Pregnant women, children, the elderly, and the immunocompromised (Batt, 2014) are most
susceptible to infection with an estimated mortality rate of 30% (CDC, 2014). While less serious
cases can mimic flu-like symptoms, more serious symptoms in high-risk groups include
convulsions, septicemia, meningitis, as well as premature delivery and stillbirth in pregnancy
associated cases (CDC, 2014). This pathogen is able to survive and grow under adverse conditions,
including salt concentrations as high as 20% (Schirmer et al., 2014), a wide pH range (5-10) (Batt,
2014), and low temperatures including those used for refrigeration (Coles et al., 1990).
Outbreaks of listeriosis have been attributed to the consumption of a variety of foods,
demonstrating the range of conditions in which L. monocytogenes can survive and grow.
According to the Centers for Disease Control and Prevention (CDC) there have been 12 recorded
listeriosis outbreaks in the United States in the past five years. These cases were linked to readyto-eat (RTE) foods that vary considerably in their levels of acidity including lettuce (pH 5.8-6.0),
caramel apples (pH 3.5-4.0), and soft cheese (pH 6.0-7.0) (CDC, 2016). As highlighted by these
outbreaks, the ability of L. monocytogenes to survive and grow over a wide range of pH values
necessitates the need to determine the efficacy of antimicrobials at different pH levels.
Many antimicrobial compounds are Generally Recognized as Safe (GRAS) by the United
States Food and Drug Administration (FDA), and have demonstrated efficacy against L.
monocytogenes and/or other prevalent pathogens in foods. For example, ε-polylysine (EPL) has
been shown to effectively reduce L. monocytogenes in a variety of food extracts, including milk,
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meats, rice, and vegetables (Geornaras et al., 2007). Similarly, there is a growing body of research
showing that lauric arginiate ethyl ester (LAE) application is effective in reducing L.
monocytogenes counts in milk and cheese (Soni et al., 2010) as well as RTE meat products
(Luchansky et al., 2005). Acidified calcium sulfate with lactic acid (ACSL) has been shown to
effectively reduce levels of L. monocytogenes in both a broth system and on various RTE foods
including ham, beef, and frankfurters (Nuñez de Gonzalez et al., 2006). Beta-resoryclic acid (BR)
is a phytophenolic compound commonly found among the angiosperms of plants (Friedman et al.,
2003). Although its antimicrobial mechanism is unknown and research is limited, it has been
shown to reduce levels of L. monocytogenes on cantaloupes (Upadhyay et al., 2014) and
frankfurters (Upadhyay et al., 2013), particularly in combination with hydrogen peroxide. In
addition to a long history of use as a disinfectant, (HP) has been shown to inhibit L. monocytogenes
in a number of food systems including cantaloupes (Upadhyay et al., 2014), frankfurters
(Upadhyay et al., 2013), and lettuce (Back et al., 2014).
Fatty acids and their derivatives have also been shown to exert antimicrobial effects against
bacteria, yeasts, and fungi (Marten et al., 2006; Kabara et al., 1972) with efficacy varying with
chain length, saturation, and bond type (Kabara et al., 1972). Caprylic acid (CA) is a medium chain
fatty acid found naturally in foods including milk and has been shown to an effective antimicrobial
against L. monocytogenes in animal based products, including milk, cheese, and RTE meats
(Gadotti et al., 2014; Lavieri et al. 2014). Data demonstrating the antimicrobial efficacy of sodium
caprylate (SC)—the soluble sodium salt form of CA—are limited. However, since SC is
completely soluble in water it may hold more practical potential in food systems.
Although antimicrobial compounds may be effective when used individually, certain
combinations may produce a combined effect greater than the sum of their separate effects referred

45

to as synergy (Brandt et al., 2011) allowing for similar or enhanced efficacy at lower individual
usage levels. This can help to limit potential negative aspects of applying antimicrobials, including
organoleptic (sensorial) changes, cost, and changes to characteristics associated with quality such
as sensory properties. For example, ACSL applied to frankfurters at high levels can create negative
sensorial changes including an increase in bitterness and astringency (Nuñez de Gonzalez et al.,
2006). Applying higher concentrations of ACSL could impact the pH of the food product, which
could negatively impact sensory attributes. Since food matrices can reduce the efficacy of
antimicrobials (i.e. protein and fats) (Ma et al., 2013; Kang et al., 2014), synergistic combinations
are desirable for reducing usage rates of individual compounds within the combination treatment
while maintaining antimicrobial efficacy.
The objectives of the present study were to determine the minimum inhibitory (MIC) and
minimum bactericidal concentrations (MBC) of ACSL, BR, CA, EPL, HP, LAE, and SC when
used alone and in binary combinations against L. monocytogenes in growth media adjusted to pH
7.4 and to pH 5.5 and to characterize the interactions as synergistic, additive, or antagonistic.
3. Material and Methods
3.1 Bacterial strains, growth conditions, and inoculum preparation
A total of eight L. monocytogenes strains were used to represent a diversity of subtypes
and sources. Strains included: F5069/ATCC 51414 (Raw Milk, DUP-1044B; serotype 4b), CWD
675-3 (Raw Milk, DUP-1053A; serotype 1a), CWD 1567 (Cheese, DUP-1038B; serotype 4b),
Scott A (DUP-1042B; serotype 4b), 2012L-5323 (Ricotta salata outbreak, 2012; serotype 1/2a),
2014L-6025 (Hispanic-style cheese outbreak, 2014; serotype 1/2b), DJD 1 (washed-rind cheese
outbreak, 2013), and CWD 193-10 U5-2 (cheese food contact surface, DUP-1030B). All strains
were from the author’s culture collections except strain DJD 1, which was kindly provided by
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Minnesota Department of Agriculture Laboratory Services Division, and strains 2012L-5323 and
2014L-6025 which were kindly provided by the CDC. Frozen (-80C) stock cultures were
inoculated into 9 ml of Brain Heart Infusion (BHI) broth (Becton Dickinson, Franklin Lakes, NJ)
and incubated at 37 ± 1C for 18 h for two subsequent transfers before use. Equal proportions of
cells from each of the eight cultures were combined as a cocktail yielding approximately 9 log
CFU/ml. The cocktail was then serially diluted in Butterfield’s Phosphate Buffer (BPB), pelleted
through centrifugation (15 min, 4200 rpm at 4°C), and re-suspended in BHI broth for use in assays.
3.2 Antimicrobials and preparations
Working stock solutions of the following antimicrobials were prepared in BHI and then
serially diluted to achieve target concentrations: CA (Sigma Aldrich, St. Louis, MO), SC (Sigma
Aldrich, St. Louis MO), BR (Acros Organic, Pittsburgh, PA), LAE (Cytoguard LA2X, A+B
Ingredients, Fairfield, NJ), EPL (25%, JNC Corporation, Tokyo, Japan), HP (30%, Acros Organic,
Pittsburgh, PA), ACSL (RTE-01, Mionix Corporation, Scottsdale, AZ). Stock solutions were
prepared in sterile distilled deionized water. Powdered BR was first solubilized in Dimethyl
Sulfoxide (DMSO) followed by dilution in BHI broth for the working stock where applicable, with
DMSO less than 4% of final assay concentration (Upadhyay et al., 2014). Stock solutions of CA
were vortexed vigorously prior to overcome low solubility and to ensure homogeneity. All
antimicrobial stocks were stored at room temperature, except for HP and EPL, which were stored
in the dark at 4˚C. Controls (negative) for each antimicrobial were included in each assay to
confirm sterility. Sterility of antimicrobial stocks were routinely verified though direct plating 100
μL of each on BHI agar and incubating at 37˚C for 24 h.
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3.3 Single antimicrobial inhibition and inactivation
Inhibitory concentrations of ACSL, BR, CA, EPL, HP, LAE, and SC were determined by
exposing L. monocytogenes at 6 log CFU/ml to serially diluted concentrations of each
antimicrobial in BHI broth using a standard broth dilution assay (Andrews, 2001) in 96-well
microtiter plates (Corning, Corning, NY). Assays were repeated in BHI broth adjusted to both pH
7.4 and pH 5.5. pH adjustments were made prior to the addition of antimicrobials using 0.1 N
NaOH or 0.1 N HCl. Plates were then incubated for 24 h at 37°C in a computer-and temperaturecontrolled microplate reader (Biotek Epoch 2; Biotek Instruments, Winooski, VT) with optical
density at 630 nm (OD630) measurements taken every 30 minutes following five seconds of orbital
shaking. Each assay included a positive control, negative controls of antimicrobial solutions as
previously mentioned, negative control of 4% DMSO (where applicable), and sterile growth media
for baseline OD correction. pH of individual wells was measured using a microtip electrode
(Accumet AB150, Fisher Scientific International Inc., Hampton, NH). Based on pilot studies (data
not shown), treatments producing <0.15 change in OD630 after 24h of incubation following
appropriate baseline adjustment across duplicate replicates were considered at least inhibitory and
selected for enumeration. To further determine inhibition or cell death using culture confirmation,
aliquots from wells with suspected inhibition were either plated directly onto BHI agar or serially
diluted in BPB before plating onto BHI agar. Plates were incubated for 48 h at 37 °C and
enumerated. The MIC was defined as the minimum concentration inhibiting L. monocytogenes
growth to levels <0.5 log CFU/ml compared to the initial inoculum level (Branen & Davidson,
2004). Concentrations of antimicrobials producing ≥3.0 log CFU/ml (99.9%) reduction in L.
monocytogenes counts from the starting level of the inoculum were classified as bactericidal
(Branen & Davidson, 2004).
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3.4 Antimicrobial interactions.
A checkerboard assay (Najjar et al., 2007; Brandt et al., 2010) was utilized to examine
interactions between binary combinations of antimicrobials at varying concentrations. Assays
were conducted in a microplate reader as described above. For each binary combination, the first
antimicrobial was serially diluted horizontally over six rows, while the second was diluted
vertically over six columns that coincided with the aforementioned rows. Each antimicrobial was
also serially diluted in a row on its own to serve as controls. Additional controls were included as
described in section 3.3 (page 49). MIC values previously determined from single antimicrobial
susceptibility tests were used as starting median concentrations for the combination assays. pH of
individual wells was measured using a microtip electrode (Accumet AB150, Fisher Scientific
International Inc., Hampton, NH). Wells that produced <0.15 change in optical density reading
were considered at least inhibitory, and were serially diluted and plated onto BHI agar. Plates were
incubated at 37˚C for 24 hours and enumerated. Combinations that produced an inhibitory or
bactericidal effect over three replicates were then characterized. Fractional inhibitory (FIC) and
bactericidal (FBC) concentrations for binary combinations of antimicrobial compounds were
determined as previously described (Hall et al., 1982). Fractional Inhibitory and Bactericidal
Concentration Indices (FICI and FBCI, respectively) were calculated to characterize compound
interactions as synergistic, additive, or antagonistic (Hollander et al., 1998). Combinations with
FICI or FBCI ≤0.50 were defined as synergistic, >0.50 and <4.0 as additive, and >4.0 as
antagonistic (Chin et al., 1997; Domaracki et al., 2000; Meletiadis et al., 2010). The following
formulae were used for each combination that resulted in inhibition or inactivation:
FIC = (Concentration of Compound 1 in interaction with Compound 2)
(MIC of Compound 1 alone)
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FICI = FIC Compound 1 + FIC Compound 2
FBC = (Concentration of Compound 1 in interaction with Compound 2)
(MBC of Compound 1 alone)
FBCI = FBC Compound 1 + FBC Compound 2
3.5 Statistical Analysis
All assays were performed in triplicate, utilizing three biological replicates and two internal
technical replicates per experiment. pH values were compared using a one-way analysis of
variance, with significance defined at p <0.05.
4. Results and Discussion
4.1 pH affects the inhibitory and bactericidal efficacy of antimicrobials.
The antimicrobials with the lowest MICs in BHI at pH 7.4 included EPL, HP, and LAE
(20, 40, and 6.25 ppm, respectively) (Table 1). When the pH was lowered to 5.5, the MICs of these
compounds increased slightly (100, 50, and 10 ppm, respectively), suggesting that they are more
effective in less acidic conditions. Values for EPL and LAE are in agreement with findings by
Brandt et al., (2010) who reported similarly low MIC values of 6.24 and 12.5 ppm, respectively,
when tested in Tryptose Phosphate Broth (TPB) at pH 7.0. Minor differences in observed MICs
could be attributed to the differences in the pH of the broth media used for the assays (7 vs. 7.4)
and/or strain differences (Brandt et al., 2010). Results comparable to those observed in the present
study have been reported for EPL and LAE in broth at pH 7.3. Inhibitory concentrations under
these conditions of have been reported as low as 10-15 ppm for EPL and from 11.8 to 23.5 ppm
for LAE (Ma et al., 2013; Techathuvanan et al., 2014; Brandt et al., 2010).
Inhibitory concentrations of HP are also in agreement with previous reports ranging from
7.4 to 75 ppm at pH 7.3, varying by strain (Romanova et al., 2002). In contrast to HP, the inhibitory
effect of ACSL, BR, CA, and SC was enhanced in the acidified broth system (Table 1), suggesting
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that these compounds are more effective at lower pH levels. As seen in Table 1, effective inhibitory
concentrations of ACSL, BR, and CA, resulted in a significant reduction in pH level. Notably,
effective inhibitory concentrations of ACSL reduced the pH to below 5.0 (Table 1), suggesting
that either higher concentrations are needed for antimicrobial efficacy or that the compound is
more effective in an acidic environment and a sufficient concentration of ACSL is needed to reduce
the pH to a level necessary for antimicrobial activity. In particular, approximate 98 and 99%
decreases in the MICs of CA and SC were observed at the lower pH values, respectively (Table
1). A buffer was considered for use in assays to prevent pH changes, however, with the number
of wells used the buffering of each well was deemed inefficient. Further studies are needed to
investigate the efficacy of these antimicrobials in a buffered system. Although data on the MIC of
CA and SC are limited, a commercial product comprised of both CA and SC has a reported MIC
of 25 ppm in TPB adjusted to pH 5.0 (Brandt et al., 2011). This is consistent with previous reports
suggesting that fatty acids may be more effective as antimicrobials in more acidic matrices (Kabara
et al., 1972). Although the efficacy of ACSL and BR were enhanced when the broth medium was
more acidic, evidence does not support that either compound is effective at near neutral pH due to
reduced pH following addition of compounds to inhibitory concentrations. Also, inhibitory
concentrations were still relatively high compared to the other antimicrobials tested. Data on the
antimicrobial effect of BR against L. monocytogenes are scant, however, reports suggest that
inhibitory and bactericidal applications of BR typically require higher usage levels of
approximately 1000 to 6700 ppm (Alves et al., 2013; Friedman et al., 2003), which is in agreement
with the findings of this study.
Similar to the inhibition assays, EPL, HP, and LAE had the lowest MBCs at pH 7.4 (60,
50, 25 ppm, respectively) (Table 2). However, when the initial pH of the broth medium was
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lowered to 5.5, the bactericidal concentrations of EPL and HP increased to 100 and 300 ppm,
respectively. The microbial inhibitory efficacy of EPL has been shown to decrease in acidic
systems, which is consistent with these findings (Najjar et al., 2007). Overall, ACSL, BR, and SC
were more effective listericides at pH 5.5 than at 7.4, whereas CA was more effective at pH 7.4
(Table 2). Similar to inhibitory concentrations, the bactericidal concentrations of ACSL, BR, and
CA significantly reduced the pH of BHI (initially 7.4) significantly compared to the control,
suggesting that either high concentrations of these compounds are necessary for bactericidal
activity or that they require low pH environments in order to produce a bactericidal effect. When
tested in broth at pH 7.4 or 5.5, ACSL reduced the pH of broth to <4.0 (3.67, 3.84, Table 2). This
increase in the efficacy of ACSL at lower pH level has been reported previously (Brandt et al.
2011) whereby a reduction in media pH from 7 to 5 reduced the MBC from 12,500 to 25,000 ppm
(strain dependent) to 1,560 ppm (Brandt et al., 2011). Minimum inhibitory concentrations of
14,000 ppm at pH 7.4 and 6,000 at pH 5.5 in the present study are in general agreement with these
results. In addition to differences between media and pH, inhibitory and bactericidal efficacy of
antimicrobials has been shown to vary between strains of L. monocytogenes (Brandt et al., 2010;
Brandt et al., 2011; Romanova et al., 2002). An eight-stain cocktail was used in the present study
to account for this variation and to increase the likelihood of including one or more strains that
have a higher tolerance to one or more antimicrobials (Ming & Daeschel, 1993). For example,
strain Scott A has demonstrated increased tolerance to several antimicrobials compared with other
strains and serotypes (Castellano et al., 2001). Also, Nobmann et al. (2009) demonstrated that CA
can have an MIC as low as 5mM, depending on the strain of L. monocytogenes that is used.
4.2 Combinatory treatments can reduce inhibitory and bactericidal concentrations.
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A total of 26 combinations were found to interact additively or synergistically to inhibit L.
monocytogenes growth (Table 3) at pH 7.4, with 10 producing inactivation (Table 4). Of the
inhibitory combinations, nine involved SC, including the two synergistic combinations (SC with
either EPL or ACSL). Five of the bactericidal combinations at pH 7.4 were classified as
synergistic. However, ACSL with SC or CA reduced the test media pH to 5.39 and 5.24,
respectively. Therefore, these pairings may produce synergy due to increased acidity, so it cannot
be concluded that synergy is produced at near-neutral pH. Two synergistic combinations involved
ACSL and SC, with one combination containing a higher concentration of ACSL and the other a
higher concentration of SC. The combination with a higher concentration of ACSL resulted in a
significant reduction in pH (Table 3), which indicates that more research is needed to determine
whether or not antimicrobial activity is due to the presence of the compound or a pH effect.
Combinations of EPL and LAE demonstrated strong synergism (i.e., FBCI of 0.292) in agreement
with previous work by Benli et al. (2011) when applied to a membrane filter model for controlling
Salmonella. In addition, usage rates for these compounds are comparably low (<10 ppm) resulting
in no significant change in media pH (Table 4).
At pH 5.5, a total of twelve combinations were inhibitory (Table 5), with three
characterized as synergistic. Acidifed calcium sulfate with lactic acid was the most common
compound among these combinations. When combined with either BR or SC, ACSL demonstrated
the highest degree of synergy based on FIC indices. Because the addition of ACSL can
significantly decrease pH, the observed inhibition in cases where pH was significantly reduced
could be pH driven. Although synergy between ACSL and EPL has been previously reported
(Brandt et al., 2010) this interaction was not observed in the present study attributed to the decrease
in efficacy of EPL at lower pH levels. A total of seven antimicrobial combinations were
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bactericidal at pH 5.5. Three of these produced a synergistic effect (Table 6), notably ACSL and
SC with an FBCI of 0.188. By definition, no inhibitory or bactericidal combinations at either pH
level were identified as antagonistic.
It is important to note that synergism only suggests the degree to which a combination
enhances efficacy compared to the sum of their individual parts. Fractional inhibitory and
bactericidal concentration indices alone should not be used to determine which treatments are most
effective overall due to the varying concentrations needed to produce the desired effects. Although
a particular combination may be characterized as synergistic, the concentrations may still not be
low enough to facilitate effective use. For example, ACSL works synergistically in multiple binary
combinations but requires relatively high usage rates which may produce negative organoleptic
changes (Nuñez de Gonzalez, 2006) and potential changes in pH. However, the identification of
synergistic combinations may be useful for reducing levels of ACSL in foods while still producing
similar antimicrobial effects.
5. Conclusions
This study identified antimicrobial compounds effective in inhibiting and inactivating L.
monocytogenes when used alone or in binary combinations in near neutral and acidic pH
environments. When used alone, HP, EPL, and LAE were the most effective inhibitory and
bactericidal compounds at pH 7.4. Hydrogen peroxide and lauric arginate were also the most
effective at pH 5.5 along with CA and SC. Although more synergistic combinations were identified
when tested in broth at pH 7.4, in several combinations with acidic compounds (especially ACSL)
significantly reduced the pH of broth. Therefore, further studies are needed to elucidate the
mechanism behind the inhibition and inactivation of L. monocytogenes in which compounds that
result in an acidic environment are used. The combination of EPL+LAE is promising for use in
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foods at near neutral pH, as it is the most synergistic listericidal combination at pH 7.4 and with
the lowest FBC indices. Sodium caprylate and ACSL are both involved in several synergistic
combinations, indicating they are promising candidates for combinatorial approaches in foods.
They also serve as a basis for future work in food systems with the ultimate goal of enhancing
practical applications to control L. monocytogenes in foods under various pH conditions. Future
studies are necessary to evaluate these combinations when applied to specific foods in order to
determine the effective concentrations in more complex matrices.
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7. Tables and Figures
Table 1. Minimum inhibitory concentrations (MIC) of antimicrobial compounds in BHI broth
adjusted to pH 7.4 and 5.5.

Antimicrobial

pH 5.5
MIC (ppm)
pHb (± SD)

pH 7.4
MIC (ppm)
pHb (± SD)

ACSL

3000

4.41 ± 0.05a

6000

4.83± 0.28 a

BR

1000

5.16 ± 0.08 a

3000

6.34 ± 0.11 a

CA
50
5.63 ± 0.02
3250
6.72 ± 0.40 a
EPL
100
5.76 ± 0.07
20
7.33 ± 0.13
HP
50
5.60 ± 0.05
40
7.39 ± 0.11
LAE
10
5.59 ± 0.05
6.25
7.37 ± 0.10
SC
50
5.53 ± 0.03
8000
7.35 ± 0.09
a
pH levels significantly different from BHI broth without antimicrobial addition (p<0.05).
b
pH of BHI broth following addition of antimicrobial compounds.
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Table 2. Minimum bactericidal concentrations (MBC) of antimicrobial compounds in BHI broth
adjusted to pH 7.4 and 5.5.

Antimicrobial

pH 5.5
MBC (ppm)

pH (± SD)

pH 7.4
MBC (ppm)

pHb (± SD)

ACSL

10000

3.67 ± 0.12 a

14000

3.84 ± 0.05 a

BR

1750

4.83 ± 0.11 a

4000

5.99 ± 0.24 a

CA

20000

5.05 ± 0.12 a

4500

6.52 ± 0.42 a

b

EPL
300
5.99 ± 0.24 a
60
7.34 ± 0.15
HP
100
5.63 ± 0.03
50
7.39 ± 0.12
LAE
20
5.57 ± 0.06
25
7.39 ± 0.17
SC
1000
5.58 ± 0.04
13000
7.25 ± 0.27
a
pH levels significantly different BHI broth without antimicrobial addition (p<0.05).
b
pH of BHI broth following addition of antimicrobial compounds.
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Table 3: Synergistic and additive inhibitory antimicrobial combinations in BHI adjusted to pH
7.4.
Concentration
Antimicrobial
(ppm)
FICc
Interaction
1
2
1
2
1
2
FICId
pHb (± SD)
ACSL
SC
5 1250
0.250 0.156 0.406
7.38 ± 0.09
Synergistic
a
ACSL
500
Synergistic
SC
2500
0.417 0.063 0.479
6.47± 0.1
a
BR
SC
1500
500
0.500 0.063 0.563
6.79 ± 0.07
Additive
ACSL
CA
625 1500
0.104 0.462 0.566
6.05 ± 0.60 a
Additive
Additive
ACSL
SC
625 4000
0.104 0.500 0.604
7.07 ± 0.08
EPL
LAE
10
1
0.500 0.125 0.625
7.39 ± 0.07
Additive
a
ACSL
BR
973.5 1500
0.156 0.500 0.656
6.53 ± 0.29
Additive
EPL
SC
1.25 5000
0.063 0.625 0.688
7.38 ± 0.08
Additive
a
CA
EPL
1500
5
0.462 0.250 0.712
6.78 ± 0.11
Additive
CA
SC
750 4000
0.231 0.500 0.731
7.15 ± 0.16
Additive
a
ACSL
SC
4000
600
0.667 0.075 0.742
5.77± 0.11
Additive
BR
SC
750 4000
0.250 0.500 0.750
7.11 ± 0.04
Additive
ACSL
SC
4500
300
0.750 0.038 0.788
5.53 ± 0.06 a
Additive
a
ACSL
BR
1250 1875
0.208 0.625 0.833
6.17± 0.37
Additive
ACSL
BR
375
750
0.625 0.250 0.875
7.01 ± 0.19
Additive
a
CA
1
Additive
LAE
2500
0.769 0.160 0.929
6.86 ± 0.33
ACSL
CA
5000
500
0.833 0.154 0.987
5.24 ± 0.13 a
Additive
a
ACSL
BR
5000
500
0.833 0.166 1.000
4.87 ± 0.35
Additive
CA
LAE
1625 3.125
0.500 0.500 1.000
7.23 ± 0.11
Additive
a
CA
EPL
3000
2.5
0.923 0.125 1.050
6.53 ± 0.29
Additive
CA
LAE
1500
4
0.462 0.640 1.102
6.76 ± 0.12 a
Additive
LAE
SC
3.125 5000
0.500 0.625 1.125
7.39 ± 0.02
Additive
HP
4
Additive
LAE
20
0.500 0.640 1.140
7.42 ± 0.02
EPL
HP
12.5
25
0.625 0.625 1.250
7.40 ± 0.03
Additive
HP
SC
25 5000
0.625 0.625 1.250
7.41 ± 0.01
Additive
a
ACSL
HP
5000
25
0.833 0.625 1.460
5.55 ± 0.31
Additive
a
pH levels significantly different BHI broth without antimicrobial (p<0.05)
b
pH of BHI broth following addition of antimicrobial compounds.
c
FIC: Fractional Inhibitory Concentration
d
FICI: Fractional Inhibitory Concentration Index; ≤0.5=Synergistic, 0.5-4.0=Additive,
>4.0=Antagonistic
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Table 4. Synergistic and additive bactericidal antimicrobial combinations in BHI broth adjusted
to pH 7.4.
Concentration
FBCc
(ppm)
Interaction
1
2
1
2
1
2
FBCId
pHb (± SD)
EPL
LAE
10 3.125
0.167 0.125
0.292
7.38 ± 0.13
Synergistic
EPL
LAE
2.5
6.25
0.042 0.250
0.292
7.39 ± 0.10
Synergistic
EPL
SC
2.5
5000
0.042 0.384
0.426
7.37 ± 0.08
Synergistic
a
Synergistic
ACSL SC
5000
1250
0.358 0.096
0.453
5.39 ± 0.14
Synergistic
ACSL CA
5000
500
0.357 0.111
0.468
5.24 ± 0.13 a
Additive
LAE
SC
6.25
5000
0.375 0.385
0.635
7.39 ± 0.09
a
Additive
ACSL BR
3750
1500
0.268 0.375
0.642
5.45 ± 0.51
CA
EPL
3000
5
0.667 0.083
0.750
7.04 ± 0.25
Additive
HP
LAE
30
5
0.600 0.200
0.800
7.39 ± 0.11
Additive
a
pH levels significantly different BHI broth without antimicrobial (p<0.05).
b
pH of BHI broth following addition of antimicrobial compounds.
c
FBC: Fractional Bactericidal Concentration
d
FBCI: Fractional Bactericidal Concentration Index; ≤0.5=Synergistic, 0.5-4.0=Additive,
>4.0=Antagonistic
Antimicrobial
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Table 5. Synergistic and additive inhibitory antimicrobial combinations in BHI adjusted to pH
5.5.
Concentration
FICc
(ppm)
1
2
1
2
1
2
FICId
pHb (± SD)
ACSL
SC
625
125
0.208
0.250
0.458
5.22 ± 0.02 a
ACSL
BR
312.5
375
0.104
0.375
0.479
5.34 ± 0.03
BR
EPL
187.5
31.25
0.188
0.313
0.500
5.47 ± 0.03
ACSL
CA
625
156
0.208
0.312
0.520
4.89 ± 0.09 a
ACSL
BR
1250
187.5
0.416
0.188
0.604
4.97 ± 0.02 a
ACSL
CA
1250
100
0.417
0.200
0.617
4.89 ± 0.09 a
BR
CA
375 156.25
0.375
0.313
0.688
5.19 ± 0.02 a
ACSL
SC
250
312.5
0.083
0.625
0.708
5.31 ± 0.05
BR
SC
375
250
0.375
0.500
0.875
5.39 ± 0.04
ACSL
HP
1250
25
0.417
0.500
0.917
4.93 ± 0.06 a
CA
LAE
312.5
3.125
0.625
0.313
0.938
5.43 ± 0.05
ACSL
HP
2500
6.25
0.833
0.125
0.958
4.59 ± 0.11 a
a
pH levels significantly different BHI broth without antimicrobial (p<0.05).
b
pH of BHI broth following addition of antimicrobial compounds.
c
FIC: Fractional Inhibitory Concentration
d
FICI: Fractional Inhibitory Concentration Index; ≤0.5=Synergistic, 0.5-4.0=Additive,
>4.0=Antagonistic
Antimicrobial
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Interaction
Synergistic
Synergistic
Synergistic
Additive
Additive
Additive
Additive
Additive
Additive
Additive
Additive
Additive

Table 6. Synergistic and additive bactericidal antimicrobial combinations in BHI adjusted to pH
5.5.
Antimicrobial
1
2
ACSL SC
EPL
SC
CA
EPL
ACSL BR
EPL
HP
EPL
SC
BR
LAE

Concentration (ppm)
1
2
1250
62.5
31.25
62.5
78.125
50
5000
375
100
50
62.5
250
375
31.25

FBCc
1
0.125
0.313
0.004
0.500
0.333
0.625
0.214

a

2
FBCId
0.063 0.188
0.063 0.375
0.500 0.504
0.214 0.714
0.500 0.833
0.250 0.875
1.560 1.777

pHb (± SD)
5.05 ± 0.11 a
5.60 ± 0.10
5.25 ± 0.12 a
4.14 ± 0.44 a
5.61 ± 0.09
5.62 ± 0.14
5.31 ± 0.02 a

pH levels significantly different BHI broth without antimicrobial (p<0.05).
pH of BHI broth following addition of antimicrobial compounds.
c
FBC: Fractional Bactericidal Concentration
d
FBCI: Fractional Bactericidal Concentration Index; ≤0.5=Synergistic, 0.5-4.0=Additive,
>4.0=Antagonistic
b
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Interaction
Synergistic
Synergistic
Synergistic
Additive
Additive
Additive
Additive

Chapter IV:
Efficacy of antimicrobials for controlling Listeria monocytogenes in milk.
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1. Abstract
Dairy-related recalls and illnesses are often attributed to Listeria monocytogenes. Although
post-lethality interventions have been identified for more acidic foods, control options are limited
for products where heating, increasing acidity, controlling water activity, and or other processing
hurdles are not practical. The objective of this study was to determine the efficacy of five
antimicrobials for controlling L. monocytogenes in milk. Stock solutions of caprylic acid (CA), polylysine (EPL), hydrogen peroxide (HP), lauric arginate (LAE), and sodium caprylate (SC) were
individually added to ultra-high-temperature pasteurized whole milk inoculated with L.
monocytogenes at 4 log CFU/ml. Samples were stored at 7°C for 21 days to mimic a mild
temperature abuse over the course of shelf life, and counts of L. monocytogenes were enumerated
weekly. Of the five antimicrobials, EPL and HP applied at concentrations within the limits set by
the FDA for use in milk significantly reduced bacterial counts over 21 days compared to the control
on day 0 (p<0.05). At 200 ppm, EPL inhibited the growth of L. monocytogenes in milk throughout
storage, while HP at 200 ppm rapidly reduced pathogen counts to undetectable levels through 21
days. Demonstrated efficacy within the acceptable usage limits set by the FDA suggests these
antimicrobials are promising approaches to control L. monocytogenes in milk and serves as a basis
for the identification of post-lethality antimicrobials treatments for use in to control L.
monocytogenes in additional dairy products.
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2. Introduction
Contamination of dairy products with Listeria monocytogenes can occur throughout the
production chain including contamination of raw ingredients or post-pasteurization from the
processing environment (Almeida et al., 2013). Though most dairy products are made from milk
that undergoes pasteurization as a lethality step, L. monocytogenes remains a substantial threat to
the dairy industry due to post-pasteurization contamination, the illegal use of raw milk in making
cheeses that require pasteurized milk, and the importation of fresh cheeses from Mexico (Gould et
al., 2014). L. monocytogenes can lead to an infection known as listeriosis when consumed by
children, the elderly, pregnant women, and/or other immunocompromised individuals. Listeriosis
initially presents itself with flu-like symptoms, but can escalate into more serious symptoms such
as meningitis, and miscarriage in pregnant women. According to the Centers for Disease Control
and Prevention (CDC) (CDC, 2016), there have been 19 reported outbreaks of listeriosis linked to
dairy products since 2003 with 168 illnesses, 132 hospitalizations, and 24 deaths. Three of these
outbreaks were linked directly to milk, and 15 to cheese. As an example, a 2007 outbreak of
listeriosis linked to pasteurized milk produced by a small dairy producer in Massachusetts that
resulted in four illnesses and two deaths highlights the need for rigorous control of postpasteurization recontamination (Anonymous, 2008). When present in milk, L. monocytogenes has
been shown to grow to high levels (6-8 log CFU/ml) during storage at refrigeration temperatures
(Donnelly & Briggs, 1986; Rosenow & Marth, 1987; Leggett et al., 2012). According to a
Quantitative Assessment of Relative Risk to Public Health from Foodborne Listeria
monocytogenes, pasteurized milk carries a high relative risk per annum despite a moderate
predicted per serving relative risk due to the fact that milk is consumed often by a large percentage
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of the population (FDA/USDA, 2003). Therefore, there is a continuous need to identify methods
to inhibit and inactivate L. monocytogenes in milk, as milk contaminated with L. monocytogenes
can be consumed directly or used in the manufacture of dairy products. The use of antimicrobial
compounds can not only reduce or eliminate L. monocytogenes in milk, but may also prevent
growth in dairy products manufactured from milk containing the antimicrobial as well.
The use of antimicrobial compounds is a practical approach for controlling pathogen
survival and growth. A number of antimicrobial compounds Generally Recognized as Safe
(GRAS) by the United States Food and Drug Administration (FDA) including caprylic acid (CA),
hydrogen peroxide (HP), lauric arginate (LAE), and -polylysine (EPL) have demonstrated
efficacy in controlling L. monocytogenes under varying experimental conditions (Amrouche et al.,
2010; Ma et al., 2000; Romanova et al., 2002; Nair et al., 2004). Caprylic acid is a medium-chain
fatty acid that is naturally occurring in foods such as milk and coconut oil that has been shown to
be effective at reducing levels of L. monocytogenes in milk (Nair et al., 2004). Although no
research to date has been conducted to investigate the efficacy of sodium caprylate (SC), the
sodium salt derivative of CA, against L. monocytogenes in milk, several fatty acid derivatives have
demonstrated antimicrobial effects against Gram positive organisms in broth (Kabara et al., 1972).
Both LAE and EPL are commercially available antimicrobial compounds that are both cationic,
relying on interaction of charge to create changes in bacterial cells. Their efficacy against L.
monocytogenes has not only been demonstrated in broth (Geornaras & Sofos, 2005; Brandt et al.,
2010), but also when applied to foods (Geornaras et al., 2007; Luchansky et al., 2005). Hydrogen
peroxide is also commercially available and has been shown to effectively inhibit the growth of L.
monocytogenes in broth at relatively low concentrations (page 58) and in sterilized milk at 495
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ppm (Dominguez et al., 1987). Currently, HP is approved for use in milk intended for
cheesemaking at levels up to 500 ppm (21 CFR 582.1366).
Studies evaluating the efficacy of antimicrobials against L. monocytogenes in milk to date
have not been carried out through the typical shelf life of milk. The shelf-life of milk is increasing
as the quality of fluid milk improves with increasing technologies and management training
(Martin et al., 2012). In fluid milk samples with low somatic cell counts, shelf-life can extend 21
days or longer, with little to no sensory defect (Ma et al., 2000). Therefore, research investigating
the efficacy of antimicrobials over the course of a potentially longer shelf-life is imperative in
order to reduce the risk of milk-related listeriosis outbreaks. The objective of this study was to
determine the ability of five antimicrobial compounds (CA, EPL, HP, LAE, and SC) to control the
growth of L. monocytogenes in UHT whole milk over 21 days of storage.
3. Materials and Methods
3.1 Bacterial strains, growth conditions and inoculum preparation
A total of eight L. monocytogenes strains were used in this study to represent a genetic
diversity of ribotypes and sources. Strains included: F5069/ATCC 51414 (Raw Milk, DUP-1044B;
serotype 4b), CWD 675-3 (Raw Milk, DUP-1053A; serotype 1a), CWD 1567 (Cheese, DUP1038B; serotype 4b), Scott A (DUP-1042B; serotype 4b), 2012L-5323 (Ricotta salata outbreak,
2012; serotype 1/2a), 2014L-6025 (Hispanic-style cheese outbreak, 2014; serotype 1/2b), DJD 1
(washed-rind cheese outbreak, 2013), and CWD 193-10 U5-2 (cheese food contact surface, DUP1030B). Strains DJD 1 was kindly provided by Minnesota Department of Agriculture Laboratory
Services Division, and strains 2012L-5323 and 2014L-6025 were kindly provided by the CDC. L.
monocytogenes strains Scott A has previously demonstrated increased tolerance to several
antimicrobials compared with other strains or serotypes in broth (Castellano et al., 2001). Frozen
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(-80C) stock cultures were inoculated into 9 ml of Brain Heart Infusion (BHI) broth and incubated
at 37 ± 1C for 18 h for two subsequent transfers prior to use. Equal volumes from each culture
were combined as a cocktail yielding ~9 log CFU/ml. The cocktail was then serially diluted in
Butterfield’s Phosphate Buffer (BPB), pelleted through centrifugation (15 min, 4200 rpm at 4°C),
and re-suspended in ultra-high-temperature pasteurized (UHT) whole milk to the target
concentration of ~5 log CFU/ml for use in the assays below. Viable numbers of L. monocytogenes
in suspension were determined by aerobic plate counts on BHI agar after serial dilution and
incubation at 37 ± 1C for 24 ± 2 h.
3.2. Antimicrobial compounds and preparation
Antimicrobial stock solutions were prepared in sterile deionized water (SDW). The
antimicrobials used included: CA (Sigma Aldrich, St. Louis, MO), EPL (25%, San-Ei Gen FFI
(USA), Inc., New York, NY), HP (30%, Acros Organic, Pittsburgh, PA), LAE (Cytoguard LA2X,
A+B Ingredients, Fairfield, NJ), and SC (Sigma Aldrich, St. Louis, MO). Caprylic acid, SC, and
LAE were stored at room temperature, while EPL and HP were stored in the dark at 4˚C. All stocks
were prepared on a volume/volume basis, except for SC which was prepared using a ratio of
weight/weight. Antimicrobial stock solutions were then serially diluted in SDW to achieve the
desired concentrations for the assays below. Stock solutions were vortexed prior to use, with CA
vortexed vigorously in order to ensure homogeneity.
3.3. Inhibition and inactivation of L. monocytogenes in milk
The efficacy of the aforementioned antimicrobial compounds against L. monocytogenes
was determined in UHT whole milk using a standard broth dilution assay (Andrews, 2001). Ultrahigh-temperature pasteurized whole milk was used to eliminate the effect of background flora and
to account for the impact of fat, which has been shown to reduce the efficacy of some compounds
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such as LAE (Soni et al., 2010). Antimicrobials were added to UHT milk in 100µl aliquots to
achieve the desired concentrations while minimizing the dilution of the milk. Three antimicrobial
compounds (HP, EPL, LAE) were tested at 100, 200, 400, and 800 ppm. Additional compounds
(CA and SC) were tested at 400, 800, 1600, and 3200 ppm. Milk samples were then inoculated
with 500µl of the L. monocytogenes cocktail to achieve a target count of 4 log CFU/ml. Inoculated
UHT milk samples with no antimicrobial were included as a positive control and uninoculated
UHT milk served as a negative control. pH of each treatment was measured using a microtip
electrode (Accumet AB150, Fisher Scientific International Inc., Hampton, NH). Samples were
stored for 21 days at 7˚C to mimic mild temperature abuse along the food supply chain, and plated
onto BHI agar on days 1, 7, 14, and 21 following serial dilution in BPB. Plates were enumerated
following incubation at 37˚C for 24 hours. The positive control was sampled on day of inoculation
to confirm the initial L. monocytogenes inoculation levels. At a given time point, inhibitory and
bactericidal activity are defined as <0.5 log CFU/ml reduction and ≥3 log CFU/ml reduction in L.
monocytogenes counts, respectively, compared to the inoculum level (Basri et al., 2014).
3.4. Statistical Analysis
Assays were performed in triplicate, with two internal replicates per sampling time point.
Bacterial counts were analyzed using the GLM procedure of SAS 9.4 (SAS Institute, Cary, NC).
The model accounts for repeated measures and includes treatment*concentration and time as main
effects. pH values were compared using a one-way analysis of variance. Data was adjusted using
Tukey’s test applied to the least squared means of treatment replicates. Significance was defined
as having a p-value of <0.05.
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4. Results and Discussion
4.1. Sodium caprylate and caprylic acid have similar efficacy against L. monocytogenes in whole
milk.
By day 14 of sampling, L. monocytogenes levels exceeded 8 log CFU/ml in milk without
addition of an antimicrobial treatment. The two highest concentrations of CA tested in the present
study (1600 and 3200 ppm) limited the growth of L. monocytogenes to levels significantly lower
than control through 14 days of storage (p<0.001). However, at 21 days, counts of L.
monocytogenes only differed significantly from the positive control for the 3200 ppm treatment
(Figure 1). At day 21, only 3200 ppm CA was inhibitory with counts that were not significantly
different from the starting inoculum level. Similarly, a minimum inhibitory concentration (MIC)
of 3250 ppm has been reported for L. monocytogenes in broth (page 58) compared to 3200 ppm in
whole milk at a similar pH of ~6.7 (Table 1). Nair et al. (2004) investigated the effectiveness of
CA in sterile whole milk at various temperatures and found that ~7200 ppm resulted in a significant
reduction of L. monocytogenes after 48 hours at 8˚C while ~3600 ppm did not. Continued efficacy
over the shelf life of milk beyond 48 hours was not determined. In the present study, counts were
not significantly lower than control until day 7, suggesting that CA at lower concentrations may
gradually reduce L. monocytogenes over time. Of the four concentrations of SC tested, two (1600,
3200 ppm) resulted in counts of L. monocytogenes significantly lower than the control on day 21
of sampling (p<0.0117 and p<.0001, respectively; Figure 2). Sodium caprylate at 3200 ppm was
the most effective treatment of the four tested, with levels of L. monocytogenes in milk with
3200ppm significantly lower than in milk with 1600 ppm of SC. There was no significant
difference between counts of L. monocytogenes on day 21 in milk with CA or SC applied at 3200
ppm (p=1.0), suggesting that the solubility of CA did not inhibit its antimicrobial activity. Both
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treatments also inhibited the growth of L. monocytogenes throughout storage as counts on day 21
did not differ significantly from inoculum level (p=1.0). However, none of the concentrations
tested were characterized as bactericidal. Higher concentrations may be necessary to see a
bactericidal effect, as observed in broth pH 7.4, in which 4500 ppm of CA and 13000 ppm of SC
were bactericidal (pages 58-59).
4.2. LAE reduces viable L. monocytogenes counts in milk at higher concentrations.
Currently, the use of LAE has been approved at levels up to 200 ppm in certain animalbased foods (FDA, 2006). Previous research has demonstrated that LAE is effective in the control
of L. monocytogenes in milk but is reduced in the presence of increasing fat content (Soni et al.,
2010). Of the four concentrations of LAE tested, 800 ppm was the only treatment that inhibited L.
monocytogenes growth, with levels of L. monocytogenes reduced by approximately 2 log CFU/ml
on day 21 of sampling compared to the starting inoculum (Figure 3). As seen in Figure 3,
treatments of 100, 200, and 400 ppm allowed for growth similar to the control throughout storage.
For 800 ppm, counts decreased steadily throughout 14 days, with limited change through the last
7 days of storage. Overall, L. monocytogenes counts decreased by ~1.7 log CFU/ml over the 21
days of storage as compared to control on day 0. No significant differences in bacterial counts
were observed between 100, 200, and 400 ppm treatments at any time point and none of these
treatments tested were inhibitory, with counts on day 21 significantly different from the starting
inoculum level (p<0.0001). Soni et al. (2010) reported similar growth patterns when 400 ppm was
used in skim milk, but found that 800 ppm of LAE lowered L. monocytogenes to undetectable
levels in both skim and whole milk, which persisted throughout storage. Similarly, Ma et. al (2013)
found that 750 ppm of LAE in 2% reduced fat skim milk resulted in a 6.20 log CFU/ml reduction
in L. monocytogenes strain Scott A. Therefore, results observed in the present study were similar
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to those reported in the literature aside from the lower efficacy reported for 800 ppm. These
differences may be attributed to differences in fat content (i.e. skim vs. whole milk) and/or
differences in strains used. The impact of fat content and other food components on the inhibitory
concentration of LAE is also demonstrated by the increase of minimum inhibitory concentration
in milk (between 400 and 800 ppm) compared to those reported for the same strains of L.
monocytogenes in broth at pH 7.4 (6.25 ppm) (page 58).
4.3. EPL treatments are inhibitory and produce gradual reductions in L. monocytogenes counts in
milk.
As shown in Figure 4, EPL treatments of 100 and 200 ppm resulted in growth inhibition,
with no significant change in counts from the starting inoculum to day 21. Treatments at 400 and
800 ppm resulted in a gradual decrease in pathogen counts from and inoculum of ~4.4 log CFU/ml
to 2 and 1 log CFU/ml, respectively, after 21 days. On day 7 of sampling, L. monocytogenes counts
were significantly lower in all treatments as compared to the control, with no significant difference
between treatments. By day 21, the 800 ppm treatment resulted in levels significantly lower than
100 and 200 ppm treatments (p<0.05). These results are similar to results reported by Geonaras et
al. (2007) investigating the efficacy of EPL in fat-free and whole milk diluted 1:10 in distilled
water. At 200 ppm, L. monocytogenes levels were lowered to undetectable levels in both extracts
after 6 days of storage. Bactericidal activity at a lower concentration of 200 ppm may be attributed
to the milk dilution performed in preparation of the milk extracts, effectively reducing the
inhibitory effect of fat and protein content within the food matrices. Geonaras et al. (2007) also
report an increase in the pH of milk with addition of EPL, which is consistent with treatments of
400 and 800 ppm in this study (Table 1). Currently, EPL is approved for use in cream and various
cheeses at a level up to 250 ppm (FDA, 2011). Similar to LAE, the inhibitory concentration of
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EPL was approximately ten-fold higher in milk than in broth at pH 7.4, where the MIC of EPL
against the same cocktail of L. monocytogenes strains was reported at 20 ppm (page 58). Again,
reductions in antimicrobial efficacy are most likely attributed to the interaction of EPL with food
components in milk such as proteins. Casein molecules carry a net-negative charge and EPL is a
surface-active positively-charged molecule. The potential binding of positively charged EPL with
negatively charged proteins could in theory reduce antimicrobial efficacy of EPL by not allowing
EPL to act on bacterial cells.
4.4. Hydrogen peroxide rapidly inactivates Listeria monocytogenes in milk.
Of the antimicrobials tested, HP was the most effective in terms of effective concentrations
used and overall inhibition and inactivation of L. monocytogenes throughout 21 days of storage.
In previous research, HP has been shown to quickly reduce L. monocytogenes counts in BHI broth
over a range of concentrations at 37˚C (Liu & Ream, 2008), and when applied at 495 ppm to
sterilized milk stored at 4˚C (Dominguez et al., 1987). In this study HP treatments were found to
be either inhibitory (100 ppm) or bactericidal (200, 400, 800 ppm) (Figure 1). Treatments at 200,
400, and 800 ppm reduced L. monocytogenes counts to undetectable levels (<1 CFU/ml) by day 7.
On day 21 of sampling, there was no significant difference in Listeria counts between any of the
treatments. However, 1-2 log CFU/ml remained after 21 days in the 100 ppm treatment group,
suggesting that 100 ppm is not enough to completely inactivate L. monocytogenes in milk when
present at initial levels of 5 log CFU/ml. Two of the three bactericidal treatments (200 and 400
ppm) and the inhibitory treatment (100 ppm) identified for HP in the present study are within
currently approved limits and do not significantly change milk pH levels (Table 1). Therefore, HP
treatments may be promising for reducing levels of L. monocytogenes in whole milk throughout
storage. Although these treatments are effective at reducing levels of L. monocytogenes, there is
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evidence that HP applied as low as 10 ppm may inhibit acid production by starter cultures even
after residual HP is seemingly neutralized using catalase (Subramanian & Olson, 1968) thereby
potentially limiting its use in the production of cultured dairy products. Future studies are needed
to investigate the rate of pathogen inactivation within the first 24 hours and detection of residual
peroxide as use in milk for cheese requires neutralization with catalase prior to processing
(Subramanian & Olson, 1968). Oxidative rancidity has been known to occur when adding HP to
foods with high fat levels (Wambura & Yang, 2011) due to free radical production, suggesting that
it could potentially cause sensorial changes in high-fat dairy products.
5. Conclusions
These data identify treatments that inactivate and inhibit L. monocytogenes in whole milk
during 21-day storage at 7˚C. Of the five antimicrobials tested, HP at 200 ppm and EPL at 100200 ppm were the most effective treatments with concentrations that fall within current approved
usage limitations. Furthermore, neither of these treatments affected milk pH. Future studies are
needed to address potential sensorial changes of effective treatments and the impact of
combinatorial antimicrobial treatments in milk in an attempt to further reduce usage levels and
increase efficacy.
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7. Figures and Tables
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Figure 1. Change in Listeria monocytogenes counts in UHT milk with caprylic acid over 21 days
of storage at 7˚C.
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Figure 2. Change in Listeria monocytogenes counts in UHT milk with sodium caprylate over 21
days of storage at 7˚C.
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Figure 3. Change in Listeria monocytogenes counts in UHT milk with lauric arginate over 21
days of storage at 7˚C.
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Figure 4. Change in Listeria monocytogenes counts in UHT milk with -polylysine over 21 days
of storage at 7˚C.
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Figure 5. Change in Listeria monocytogenes counts in UHT milk with hydrogen peroxide during
storage at 7˚C.
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Table 1. pH of ultra-high-temperature pasteurized whole milk containing antimicrobials at
varying concentrations on day of inoculation.
Treatment Concentration (ppm)
Control
CA
400
800
1600
3200
EPL
100
200
400
800
HP
100
200
400
800
LAE
100
200
400
800
SC
400
800
1600
3200
a
b

pHb ± SD
6.67±0.02
6.68±0.03
6.70±0.00
6.69±0.02
6.69±0.01
6.67±0.02
6.71±0.01
6.83±0.01a
6.78±0.04a
6.66±0.01
6.68±0.00
6.68±0.01
6.68±0.00
6.57±0.02a
6.53±0.02a
6.52±0.02a
6.53±0.02a
6.72±0.01a
6.75±0.01a
6.74±0.03a
6.73±0.12a

pH significantly different from control (UHT milk without antimicrobial added) (p<0.05).
pH of milk with added antimicrobials at time of inoculation.
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Chapter V
Efficacy of antimicrobials and their combinations
for controlling Listeria monocytogenes in Queso Fresco.
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1. Abstract
The efficacy of individual and combinatory treatments of acidified calcium sulfate with
lactic acid (ACSL), ε-polylysine (EPL), hydrogen peroxide (HP), lauric arginate ethyl ester (LAE),
and sodium caprylate (SC) to control Listeria monocytogenes as surface contaminants on fresh
cheese [Queso Fresco (QF)] was investigated. Antimicrobial treatments applied in the form of
aqueous dips included: HP 5%, LAE 2%, LAE 5%, EPL 10%, SC 10%, ACSL 25%, LAE
5%+EPL 10%, EPL 10% + SC 10%, ACSL 25% + SC 10%, and LAE 5% + SC 10%.
Combinations were tested to identify potential additive, synergistic, or antagonistic activity. Queso
Fresco was inoculated with an eight-strain cocktail of L. monocytogenes at ~4 log CFU/g, dipped
in antimicrobial solutions, vacuum-packaged, and then stored at 7˚C for 35 days. Listeria
monocytogenes counts were determined 24h after dip application and weekly throughout storage.
Dip treatments in HP at 5% resulted in a decrease in L. monocytogenes counts to <1 log CFU/gram
by 24 hours, which remained below this level through 35 days of storage. Dip treatments in a 10%
solution of SC resulted in significantly lower counts of L. monocytogenes compared to the control
on day 35. Combinatory treatments of EPL + LAE did not result in levels of L. monocytogenes
lower than either compound alone. However, the combinations ACSL + SC, EPL + SC, and LAE+
SC produced reductions in L. monocytogenes counts that were significantly lower than the control
throughout storage and significantly lower than each of the compounds applied individually. These
data indicate that HP dip treatments and several combinatory treatments are effective methods for
inhibiting and inactivating L. monocytogenes on QF throughout 35-day shelf-life.
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2. Introduction
Each year, approximately 1 in 6 Americans fall victim to foodborne illness caused by
pathogenic foodborne microorganisms (CDC, 2016) with an estimated financial burden of $77.7
billion dollars (Scharff, 2012). Dairy foods are the second most common food category after
produce implicated in foodborne illness outbreaks. Of the 31 known biological agents that cause
foodborne illness, Listeria monocytogenes is the third leading cause of foodborne-illness related
deaths, with an estimated 260 deaths per year (CDC, 2016). Furthermore, the presence of Listeria
or suspected presence in foods can lead to recalls, which causes a financial burden to producers.
Therefore, there is a continuous need for the development of methods to prevent listeriosis
outbreaks and Listeria-related recalls.
Mexican/Hispanic-style soft cheeses, notably Queso Fresco (QF), have been the source of
several listeriosis outbreaks and recalls in recent years. Ques Fresco is a fresh, mild cheese, popular
amongst the Hispanic community (Van Hekken et al., 2012). In 2015, 30 persons across 10 states
were hospitalized due to the consumption of soft cheeses, including QF, which had been
contaminated with L. monocytogenes (FDA, 2016). This fresh cheese has a short shelf-life of ~ 35
days (Leggett et al., 2012), and is usually consumed before the end of shelf life is reached. In the
United States, the Code of Federal Regulations (CFR) Title 21 mandates pasteurization of milk for
the production of non-standardized cheeses including fresh soft cheeses like QF (21 CFR 1240.61).
Although pasteurization of milk used in the manufacture QF is mandatory in order for it to be sold
across state lines, outbreaks have been linked to cheeses made with improper pasteurization or the
use of unpasteurized milk mixed in with pasteurized milk (Gould et al., 2014; Genigeorgis et al.,
1991). In outbreaks linked to pasteurized cheese, contamination occurs due to presence and
persistence of L. monocytogenes in the processing facility. Research indicates that L.
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monocytogenes is commonly found in processing facilities drains, on floors, and on worker boots,
and can persist in the same facility for multiple years (D’Amico and Donnelly, 2009). Research
has shown that L. monocytogenes can grow to levels >7 log CFU/gram in QF over 35 days of
storage at 4˚C and more rapidly at 10˚C (Leggett et al., 2012). Queso Fresco supports the survival
and growth of L. monocytogenes due to its high moisture, low salt, and relatively high pH (>6.0)
(Van Hekken et al., 2012).
In an effort to control L. monocytogenes outbreaks and recalls, the USDA Food Safety
Inspection Service (USDA-FSIS) has issued a final rule for ready-to-eat (RTE) meats and poultry,
requiring that producers of these foods employ one of three alternatives to control L.
monocytogenes as post-lethality contaminants. Several antimicrobial compounds have
demonstrated efficacy in the control of L. monocytogenes (Koseki et al., 2007; Lavieri et al., 2014;
Luchansky et al., 2005; Upadhyay et al., 2013), suggesting they may be promising approaches for
the control of L. monocytogenes in dairy foods. However, such treatments can produce sensorial
changes in the foods which they are applied to (Smith et al., 2015), including changes in color,
odor, and taste. In a study conducted on QF in which antimicrobials were applied to curds, Gadotti
(2011) found that addition of antimicrobials (caprylic acid, nisin, cinnamaldehyde) produced a
significant “off-flavor”, and the overall liking of the QF decreased (Gadotti 2011). Therefore, it is
desirable to use combinations of antimicrobials to produce a synergistic effect, in which
compounds used together produce greater combined effect in comparison to the sum of their
separate effects (Brandt et al., 2011). By using synergistic combinations, the usage levels of each
antimicrobial in the combination can be reduced, which can limit these sensory effects.
Antimicrobials with demonstrated anti-listerial efficacy when used alone or in combinations
include acidified calcium sulfate with lactic acid (ACSL), ε-polylysine (EPL), hydrogen peroxide
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(HP), lauric arginate ethyl ester (LAE), and sodium caprylate (SC) (Chapter III; Brandt et al., 2011;
Brandt et al., 2010; Dominguez et al., 1987). The application of antimicrobials can also reduce the
natural microflora of QF (Gadotti, 2011), which could potentially extend the shelf life of the
cheese. The purpose of this study was to determine the efficacy of these five antimicrobial
compounds on their own and in combination for the control of L. monocytogenes as surface
contaminants on QF throughout storage at 7˚C for 35 days.
3. Materials and Methods
3.1. Bacterial strains, growth conditions and inoculum preparation
A total of eight L. monocytogenes strains were used in this study to represent a genetic
diversity of ribotypes and sources. Strains included: F5069/ATCC 51414 (Raw Milk, DUP-1044B;
serotype 4b), CWD 675-3 (Raw Milk, DUP-1053A; serotype 1a), CWD 1567 (Cheese, DUP1038B; serotype 4b), Scott A (DUP-1042B; serotype 4b), 2012L-5323 (Ricotta salata outbreak,
2012; serotype 1/2a), 2014L-6025 (Hispanic-style cheese outbreak, 2014; serotype 1/2b), DJD 1
(washed-rind cheese outbreak, 2013), and CWD 193-10 U5-2 (cheese food contact surface, DUP1030B). Strains DJD 1 was kindly provided by Minnesota Department of Agriculture Laboratory
Services Division, and strains 2012L-5323 and 2014L-6025 were kindly provided by the CDC.
Frozen (-80C) stock cultures were inoculated into 9 ml of Brain Heart Infusion (BHI) broth and
incubated at 37 ± 1C for 18 h for two subsequent transfers prior to use. Equal volumes from each
culture were combined as a cocktail yielding ~9 log CFU/ml. Viable numbers of L. monocytogenes
in suspension were determined by aerobic plate counts on BHI agar after serial dilution, incubated
at 37 ± 1C for 24 ± 2 h. The cocktail was then serially diluted in Butterfield’s Phosphate Buffer
(BPB), pelleted through centrifugation (15 min, 4200 rpm at 4°C), and re-suspended in BPB to the
target concentration of ~5 log CFU/ml for use in the assays below. Cell counts of starting inoculum
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were confirmed through serial dilution and enumeration on BHI agar following incubation at 37˚C
for 18-24 hours.
3.2. Cheese manufacture.
Queso Fresco was manufactured in the University of Connecticut Creamery in a Kusel
double-O style cheese vat according to a standard protocol using 50 gallons of pasteurized cow’s
milk standardized to 3.5% fat using skim milk and cream (Garelick Farms, Franklin, MA). Briefly,
calcium chloride (CaCl2 0.02% v/v) was added to the milk after filling the vat and thoroughly
mixed. Milk temperature was raised to 32C and pH was adjusted to 6.45 with dilute lactic acid
(50% v/v in sterile water) (85% lactic acid, Sigma-Aldrich, St. Louis, MO). Chymosin (DCI Star
Double strength microbial rennet, Dairy Connection, Madison, WI) was added at 15.83ml/100
liters and milk was stirred for approximately 45 seconds to mix. Once desired firmness was
reached, the coagulum was cut into 1x1 cm curds using sanitized stainless steel curd knives.
Cutting time was determined with the following equation: cutting time = time of flocculation +
(time of flocculation x 2). Curds were allowed to rest for 5 min and then stirred for 5 min, which
was repeated for three cycles (a total of 30 minutes). After an additional 5 min rest, the majority
of the whey was removed by draining. The curds were then transferred to standard 20# Wilson
hoops lined with disposable cheese cloth and pressed at ~10 PSI in a room maintained between
20-25C for 20 minutes. Cheeses were then removed from the hoops, broken up and salted with
kosher salt (Diamond Crystal, Cargill, Wayzata, MN) to obtain a final NaCl concentration of ~2%.
Salted curds were returned to the hoops and pressed ~10 PSI for an additional 75 min. Cheese
blocks were then vacuum packaged and stored at 4˚C prior to cutting into experimental units within
48 hours.

91

3.3. Physicochemical analysis of cheese.
Cheese composition is provided in Table 1. Cheese characteristics were targeted based on
previous work identifying cheese compositions associated with Listeria presence (Lovett et al.,
1987). Physiochemical analysis was conducted on the cheese following manufacture including pH
(Accumet AB150 with microtip electrode, Fisher Scientific International Inc., Hampton, NH), dry
matter (DM; after drying to constant weight at 102C), fat (Babcock method), and salt (NaCl as
chloride) (Quanttab Chloride, Hach, Loveland, CO). Salt in the aqueous phase, moisture in the
non-fat substance (MNFS), and fat in water free substance were determined using the formulae:
Salt in the aqueous phase = (salt/ (100-DM))*100; MNFS = (100-DM/ (100-fat))*100; Fat in water
free substance = (fat/DM)*100.
3.4. Cheese sample preparation and inoculation
For each trial, samples weighing 25  1g were cut from refrigerated vacuum packaged
cheese blocks using sterile knives. For each 25g sample, 100µL of the inoculum was spread over
a single surface (~6 cm2) with a sterile spreader, in order to attain a target contamination level of
4 log CFU/g. Inoculated samples were allowed a 30-minute drying period to enable bacterial
attachment prior to dipping application.
3.5. Antimicrobial dip preparation and application
Antimicrobial dip solutions were prepared in sterile deionized water (SDW) in sterile
containers. Antimicrobials used are as follows: ACSL (Mionix Corporation, Scottsdale, AZ), EPL
(25%, San-Ei Gen FFI (USA), Inc., New York, NY), HP (30%, Acros Organic, Pittsburgh, PA),
LAE (Cytoguard LA2X, A+B Ingredients, Fairfield, NJ), and SC (Sigma Aldrich, St. Louis MO).
Dip solutions were prepared on a volume/volume basis, except for EPL and SC which were
prepared using a ratio of weight/weight. Sample preparation for days 1, 7, 14, 21, 28, and 35
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included two inoculated samples dipped in the appropriate aqueous antimicrobial dip solution and
two dipped in SDW to serve as controls. Although the volume of antimicrobial dip solution
transferred to each individual cheese unit can vary, the approximate transfer of antimicrobial
solutions to 25g cheese samples was determined to be ~0.2g. This approximate value was used to
estimate antimicrobial concentrations (ppm) in finished product (Table 2). Dip concentrations
were selected based on preliminary data to identify potential inhibitory, subinhibitory, and
bactericidal concentrations within limits presented by federal regulations and obvious sensorial
changes. Single antimicrobial treatments were as follows: 3% HP (250 ppm), 5% HP (400 ppm),
10% SC (800 ppm), 25% ACSL (2000 ppm), 10% EPL (800 ppm), and LAE at both 2% (150 ppm)
and 5% (400 ppm). Percentages reflect the antimicrobial concentration in the aqueous dip whereas
ppm reflects the approximated final antimicrobial concentration per gram of cheese. Antimicrobial
treatments were also tested in combinations through sequential application: 2% LAE + 10% EPL;
5% LAE + 10% EPL; 10%SC + 25% ACSL; 10% EPL + 25% ACSL; and 10% EPL + 10% SC.
After inoculation and drying, cheese samples were submerged in respective antimicrobial solutions
at room temperature for one minute, then placed in vacuum bags (3 mil, UltraSource LLC, Kansas
City, MO), vacuum-sealed, and stored at 7˚C. For combinations, cheese samples were dipped
sequentially in two separate antimicrobial solutions, with one minute between the first and second
application. The order of antimicrobial application was based on preliminary trials (data not
shown).
3.6. Listeria monocytogenes enumeration
At each sampling time point, cheese samples were removed from refrigerated storage and
homogenized in 100 ml of Dey-Engley broth (DE; Becton, Dickinson and Company, Sparks, MD)
in a Smasher stomacher (Biomerieux, France) for 1 minute at 560 strokes/minute to neutralize
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antimicrobials. Bags were then briefly hand mixed to ensure consistent homogenization.
Following serial dilutions in Butterfield’s Phosphate Buffer (BPB), homogenates were plated onto
Modified Oxford Agar (MOX), incubated at 37˚C for 48 hours, and enumerated. On day 0 (day of
inoculation), two inoculated samples receiving no dip application were processed to confirm initial
inoculation levels. Two uninoculated negative controls were also processed to confirm absence
(<5 CFU/g detection limit) of L. monocytogenes in uninoculated QF. Listeria monocytogenes on
MOX plates were enumerated following incubation at 37˚C for 24-48 hours.
3.7. Analysis
For each treatment, inhibitory and bactericidal activity, as well as synergism, were defined
based on previous work (Basri et al., 2014). At a given time point, inhibitory and bactericidal
activity are defined as <0.5 log CFU/g change and 3 log CFU/g reduction in L. monocytogenes
counts, respectively, compared to the inoculum level. Synergistic interactions of the combined
treatments were defined as 2 log CFU/g reduction in L. monocytogenes counts compared to the
most active antimicrobial on its own.
Experiments were performed in triplicate using three independently produced batches of
cheese, with two samples per treatment per time point. Bacterial counts were analyzed using the
GLIMMIX procedure of SAS 9.4 (SAS Institute, Cary, NC). The model included
treatment*concentration and time as major effects. Data was adjusted using Tukey’s test applied
to the least squared means of treatment replicates. Significance was defined as having a p-value
of <0.05.
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4. Results and Discussion
4.1. Hydrogen peroxide rapidly inactivates L. monocytogenes on QF.
In samples of cheese without antimicrobial treatment, L. monocytogenes reached 8 log
CFU/g at day 21 of sampling. Treatments in a 5% solution of HP (400 ppm in final product) for
60 seconds reduced counts of L. monocytogenes to <1 log CFU/g by day 1 of sampling, with counts
remaining consistently at this level throughout the remainder of storage. With an approximate 3.5
log decrease from the starting inoculum (Figure 1), this treatment was considered bactericidal.
Levels of L. monocytogenes remained significantly lower than the control and remained below 1
log CFU/g (<0.05) at all sampling days. On the final day of storage (day 35), counts for treated
cheese samples were 7.5 log CFU/g lower than the control. These data are in agreement with those
observed in milk, as 400 ppm of HP in milk reduced L. monocytogenes counts to undetectable
levels throughout storage at 7˚C for 21 days (page 82). Results from HP treatments at 3% were
inconsistent (data not shown). These inconsistencies were attributed to the use of different lots of
HP and the possible degradation of one lot over time. The results from one set reflected results
expected of 250 ppm of HP in final product, as 200 ppm in milk resulted in undetectable levels of
Listeria monocytogenes throughout storage (page 82). If HP behaves similarly in milk and QF as
the results of a 400 ppm treatment suggests, it is most likely that the HP used in the less effective
trial was in fact degraded. The use of aqueous HP dips has been successful at reducing L.
monocytogenes levels on other foods as well. When cantaloupes were washed with a 2% aqueous
solution at 55˚C, levels of L. monocytogenes decreased by 4 log CFU/gram after 10 minutes
(Upadhyay et al., 2013).
4.2. EPL and LAE have limited inhibitory effects against L. monocytogenes on QF when used
alone and in combination.
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Based on data from Chapter III showing that LAE and EPL produce inhibition and
inactivation at low concentrations, these antimicrobials were first tested individually. Each
individual treatment resulted in L. monocytogenes counts lower than the control up to 7 days of
storage and LAE treatments at 5% remained below control through 14 days of storage. Both
treatments of LAE produced 2 log reductions within the first 24 hours of storage and resulted in at
least a one log reduction in L. monocytogenes counts compared to the control throughout 21 days
of storage. By day 35 of sampling there was no significant difference in L. monocytogenes counts
in samples treated with either LAE at 2% or 5%, compared to the control (p=0.99). This is in
agreement with previous research, which consistently shows that LAE produces an initial
inactivation with no inhibitory effect (Porto-fett et al., 2010; Lavieri et al., 2014). As shown in
Table 1, the final concentrations of LAE on cheese was approximated at 150 and 400 ppm for the
2% and 5% dips, respectively. Soni et al. (2010) observed that both 200 and 800 ppm of LAE
applied to QF resulted in an initial reduction in L. monocytogenes counts, followed by regrowth.
In this study counts reached 8 log CFU/g for the 200 ppm treatment and 6 log CFU/g for 800 ppm
day 28 (Soni et al., 2010). These results are in agreement with the results of the present study as
well, showing that LAE successfully reduces L. monocytogenes initially but may not be effective
for preventing growth over extended shelf-life on its own. In a study by Taylor (2013), it was
observed that lower starting inoculums (1 or 2 log vs. 4 log), delay the onset of L. monocytogenes
growth on cheese agar. Therefore, further studies are needed to determine if LAE could inhibit L.
monocytogenes on QF at a lower starting inoculum.
Based on synergistic bactericidal effects of LAE and EPL in combination against L.
monocytogenes in broth pH 7.4 (page 61), antimicrobial solutions of EPL at 10% were tested with
LAE at both 2% and 5%. Cheese samples were dipped in EPL before LAE, based on previous
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studies showing that this sequence produced a greater reduction in Salmonella on chicken
carcasses (Benli et al., 2011). The combined treatment with EPL with either concentration of LAE
did not produce counts significantly different than the respective concentration of LAE alone
(Figures 2 and 3). By 28 days of storage, neither EPL, LAE, nor any combination resulted in
significantly different counts than the control (p >0.77). When applied to milk, the efficacy of both
EPL and LAE decreased compared to broth (pages 58 and 59), as evidenced by the ~10-fold
increase in inhibitory concentrations. Protein and fat levels are higher in cheese than in milk due
to the removal of whey; therefore, it can be speculated that the efficacy of EPL+LAE both alone
and in combination against L. monocytogenes is diminished in food matrices due to the high levels
of fat and protein. Similar observations were reported for the application of EPL+LAE to chicken
carcasses (Benli et al., 2011), whereby the combination was more effective against Salmonella on
filters than chicken carcasses.
4.3. Sodium caprylate produces greater antimicrobial effects when used in combinations.
Of the three individual treatments LAE 5%, EPL 10%, ACSL 25%, no treatment resulted
in significantly lower counts of L. monocytogenes compared to the control on day 35 of storage
(p<=1, p=1, p=.9102, respectively). On its own, ACSL applied at 25% resulted in a 2 logCFU/g
reduction in L. monocytogenes counts through 28 days of sampling, and at 35 days of sampling
counts were not different from the control. However, SC applied alone at 10% resulted in a 1.5 log
CFU/g reduction in L. monocytogenes compared to the control on day 35 (p=0.0001). When noninhibitory treatments (LAE 5%, EPL 10%, ACSL 25%) were applied in combination with SC at
10%, L. monocytogenes counts were significantly lower than the control at all days of sampling
(p<0.05). Also, each combinatorial treatment resulted in counts that were significantly lower than
either individual treatment alone at 35 days of storage. However, final bacterial counts on day 35
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did not differ significantly between any of these treatments. This is important because it then
allows producers choices as to which antimicrobials to use, taking into consideration cost and
potential sensorial changes. L. monocytogenes counts on QF treated with SC in combination with
EPL returned to initial inoculation levels by day 21, whereas treatments of ACSL + SC were
approximately 1 log lower (Figures 4 and 6, respectively). Combinatory treatments of ACSL + SC
were also identified as synergistic (Figure 6).
5. Conclusions
Across all treatments, HP 5% (400 ppm) was the most effective treatment for reducing
levels of L. monocytogenes, with counts staying below 1 log CFU/g throughout storage, indicating
bactericidal activity. In addition to HP, SC 10% was the only single treatment that resulted in
delayed growth compared to the control; however, counts still reached >7 log CFU/g by day 35,
showing that it was not inhibitory over the entire shelf life. Effective combinatorial treatments
included SC 10% combined with either ACSL 25%, LAE 5%, or EPL 10%, which resulted in
levels of L. monocytogenes 2-4 log CFU/g lower than the control on the final day of storage. The
combination of ACSL + SC produced a synergistic effect. Therefore, application of antimicrobial
solutions containing either HP 5% or SC in various combinations are promising approaches for
controlling L. monocytogenes on QF. Future studies are needed to evaluate the survival of L
monocytogenes in antimicrobial dip solutions to identify the possibility of cross contamination of
cheese through antimicrobial dip applications, as well as potential sensorial changes.
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7. Tables and Figures

Table 1. Composition of Queso Fresco.

Batch
1
2
3
Average

Dry
Matter
47.23
47.36
45.53
46.71

Moisture
52.77
52.64
54.47
53.29

Fat
21
21
21.75
21.25

Salt
2.15
2.1
2.12
2.12

Moisture in the
Nonfat Substance
66.8
66.6
69.6
67.67
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Salt in the
Aqueous Phase
4.1
4
3.9
4.00

Fat in WaterFree Substance
44.5
44.3
47.8
45.53

Table 2. Approximate concentration of antimicrobials in Queso Fresco following antimicrobial
dip application. Concentrations are based on a 0.2g transfer of aqueous dip solution to 25±1g
samples of cheese.

Antimicrobial
ACSL
EPL
HP
HP
LAE
LAE
SC

Dip Concentration
(%)
25
10
5
3
2
5
10

Approximate Concentration in
Cheese (ppm)
2000
800
400
250
150
400
800

103

10
9
8

Count (logCFU/g)

7
6

5

Control

4

HP 5%

3
2
1
0
0

7

14

21
Time (days)

28

35

Figure 1. Changes in Listeria monocytogenes counts on Queso Fresco during storage at 7˚C
following dip application of hydrogen peroxide (HP).
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Figure 2. Changes in Listeria monocytogenes counts on Queso Fresco during storage at 7˚C
following dip application of -polylysine (EPL), lauric arginate ethyl ester (LAE), and both
antimicrobials sequentially (Combined).
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Figure 3. Changes in Listeria monocytogenes counts on Queso Fresco during storage at 7˚C
following dip application of -polylysine (EPL), lauric arginate ethyl ester (LAE), and both
antimicrobials sequentially (Combined).
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Figure 4. Changes in Listeria monocytogenes counts on Queso Fresco during storage at 7˚C
following dip application of -polylysine (EPL), sodium caprylate (SC), and both antimicrobials
sequentially (Combined).
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Figure 5. Changes in Listeria monocytogenes counts on Queso Fresco during storage at 7˚C
following dip application of lauric arginate ethyl ester (LAE), sodium caprylate (SC), and both
antimicrobials sequentially (Combined).
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Figure 6. Changes in Listeria monocytogenes counts on Queso Fresco during storage at 7˚C
following dip application of aqueous solutions of acidified calcium sulfate with lactic acid
(ACSL), sodium caprylate (SC), and both antimicrobials sequentially (Combined).
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Chapter VI
Summary
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Listeria monocytogenes is the major bacterial pathogen associated with foodborne
infections linked to dairy foods and is one of the leading causes of death related to foodborne
illness. Mexican-style soft cheeses are of particular concern due to their high moisture and pH, and
low salt content. Because this pathogen is persistent in food-processing facilities and can survive
refrigeration temperatures, there is a continuous need to develop methods to reduce contamination
levels and/or inhibit its growth.
This research determined the efficacy of antimicrobials used alone and in combination for
the control of L. monocytogenes in broth, whole milk, and Queso Fresco (QF). The first objective
of this study was to determine the efficacy of antimicrobials against L. monocytogenes in a broth
system at pH 7.4 and acidified to 5.5. Hydrogen peroxide (HP), -polylysine (EPL), and lauric
arginate ethyl ester (LAE) were the most effective antimicrobials when used against L.
monocytogenes in broth at the near neutral pH of 7.4. These antimicrobials maintained efficacy in
an acidified broth (pH 5.5). The efficacy of caprylic acid (CA) and sodium caprylate (SC) was
enhanced in the acidified system. Overall, the most synergistic antimicrobial pairing in broth at
pH 7.4 was EPL+LAE. However, SC was a component of approximately half of all synergistic
combinations identified across both pH levels.
The second objective of this study was to determine the efficacy of antimicrobials against
L. monocytogenes in ultra-high-temperature pasteurized whole milk. In whole milk, the inhibitory
concentrations of EPL and LAE both increased by tenfold, while inhibitory concentrations of CA
and SC were similar to the inhibitory concentrations identified in broth at pH 7.4. Hydrogen
peroxide was the most effective of the antimicrobials, producing a bactericidal effect at 100 ppm
and no detectable growth at 200 ppm.

111

The third objective was to determine the efficacy of antimicrobials in the form of aqueous
dips against L. monocytogenes on surface-contaminated QF, both alone and in combination.
Hydrogen peroxide applied as a 5% aqueous dip solution to QF was the only antimicrobial that
was bactericidal when applied alone. Following this treatment, less than 1 log CFU/gram was
recovered from QF samples throughout 35 days of storage. The most effective antimicrobial
combinations applied to QF as binary combinations included ACSL 25% + SC 10%, LAE 5% +
SC 10%, and EPL 10% + SC 10%. Of these three treatments, by definition only ACSL 25% + SC
10% produced a synergistic effect.
These results together suggest that antimicrobial treatments utilizing the aforementioned
antimicrobials are effective at reducing and/or inhibiting the growth of L. monocytogenes.
Antimicrobial efficacy was determined in broth at two pH levels, identifying antimicrobials that
may be more effective at different acidity levels. Notably, CA and SC showed a dramatic increase
in antimicrobial efficacy in acidified broth. In milk, antimicrobial efficacy of CA and SC was
similar as in broth pH 7.4, whereas efficacy of EPL and LAE decreased in milk. Hydrogen
peroxide shows the most promise as an antimicrobial treatment in both milk and cheese, with
bactericidal activity remaining consistent throughout storage. Applied to QF, LAE +SC, EPL +SC,
and ACSL + SC are able to effectively reduce L. monocytogenes contamination and therefore
should be studied further to determine consumer acceptability.
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